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Chapter 1
Introduction
Each year, cancer is diagnosed in 17 million people worldwide. Radiation therapy (ra-
diotherapy) is one of the main treatment modalities, together with surgery and chemo-
therapy. It can be used for curative tumor eradication, tumor size reduction, tumor bed
cleansing or palliative purposes.
Radiotherapy uses ionizing radiation to inflict damage on tumor cells for eradication
of the disease. The main technique is the use of external X-ray beams that interact with
tissue, resulting in delivered radiation dose in the patient. This is called external beam
radiation therapy (EBRT), which was used for the studies in this thesis.
The ionizing beams are generated by a LINear ACcelerator (linac) and routed toward
the patient. While the beam passes through the patient, it interacts and delivers dose
to all tissues, not only the malignant ones. Healthy cells can therefore also be aected
by the treatment. It is physically impossible to fully spare them while also delivering a
dose to eradicate the tumor. Thus, an important goal of a treatment is to maximally limit
the possible negative impact of the irradiation on the patient’s Quality of Life (QoL) by
limiting dose delivery to healthy tissues.
In order to minimize dose to healthy tissues, multiple beams are targeted at the tu-
mor, essentially creating a cross-fire. As a result, the surrounding dose is relatively low,
which contributes to reducing the damage to healthy tissues. An important challenge
lies in selecting a beam geometry (number of beams and directions) which is 1) able to
deliver the desired minimum dose to the tumor, and 2) maximally reduce the dose to
the surrounding healthy tissues.
Since some healthy tissues are more radiosensitive than others, dierent trade-os
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are generally required, e.g. it may be desirable to not let a radiation beam pass through
some tissues at all. This type of knowledge on the healthy tissues surrounding the tu-
mor has to be taken into consideration when beam geometry and beam contributions
(intensity profiles) are defined.
Background of the performed investigation
In the common intensity-modulated radiotherapy (IMRT), treatment planning is the
process of defining the beam geometry and intensity profiles for delivery of the pre-
scribed tumor dose, while minimizing the dose to radiosensitive healthy tissues (organs-
at-risk, OAR) surrounding the tumor.
In current clinical practice, the beam geometry is usually defined by a template (the
same beam configuration for all patients with a certain tumor type) which may be adap-
ted by the planner for an individual patient. Alternatively, the planner can select angles
from experience. Generally, it is not known whether the selected beam setup can be
significantly improved or not.
A linac can rotate the beam over 360◦ around the patient, with beam directions per-
pendicular to the patient’s axis. These are called coplanar beams. In addition, the pa-
tient couch can also rotate, resulting in non-coplanar beams. Allowing non-coplanar
setups highly increases the degrees of freedom in beam selection, which can result in
significant increases in plan quality. However, allowing non-coplanar plans can imply
i) an increased complexity in choosing beams, especially due to the current lack of cli-
nically available beam angle optimization (BAO) algorithms, ii) an increased treatment
time, especially for linacs that only have manual couch rotation, and iii) an reduced de-
livery accuracy in case the patient moves as a reaction to the moving couch. In clinical
routine, there is often the tendency to upfront exclude non-coplanar setups.
Treatment plans are generated with the aid of a commercial software application,
called Treatment Planning System (TPS). In the worldwide mostly applied conventional
planning, this is done in an interactive trial-and-error procedure (manual planning).
Based on the initially selected beam geometry, the planner defines a mathematical opti-
mization problem (i.e. cost functions, objectives, weights and/or additional parameters)
that is subsequently used by the computer to generate beam intensities profiles. If the
result is a not high-quality plan, the planner can e.g. modify the optimization problem
or change beam geometry for another run of optimization. This interactive and iterative
process stops if the plan is considered adequate, or if there are no more ideas or time,
or if significant improvements with further optimization are considered unlikely.
Automation of treatment planning has the potential to avoid inter- and intra-planner
variability in plan quality and to minimize planning time, depending on the applied au-
12
1
1
 Introduction
toplanning algorithm. In our institute, Erasmus-iCycle was developed for automated
planning [22]. It is a system for a priori multi-criterial plan optimization [73]. For each
patient, a single plan is generated that is both Pareto-optimal and clinically favourable
[23]. Erasmus-iCycle is in use since 2010, both for research and for clinical planning
[25, 38, 67, 69, 144, 145, 155, 159, 185, 186]. The system features integrated optimization of
beam profiles and (non-coplanar) beam geometries. This unique feature was intensively
employed for the investigations in this thesis.
The performed investigations
Erasmus-iCycle was used to systematically investigate the impact of beam configura-
tions on plan quality, and to investigate plan quality improvements relative to conven-
tional manual planning. The automated planning allowed generation of large numbers
of plans for statistically firm conclusions, and for investigating multiple alternative beam
configuration approaches.
In Chapter 2, Erasmus-iCycle was used to investigate plan quality variations related to
dierent beam geometries, with a focus on non-coplanar vs. coplanar setups, and on
the number of applied beams. Hereto, 1500 plans were generated for 10 patients.
In Chapter 3, non-coplanar beam angle class solutions for prostate SBRT were de-
veloped and compared with individualized BAO with Eramus-iCycle. Aim of the investi-
gations was to explore avoidance of time consuming, individualized BAO. Moreover, a
beam angle class solution could potentially be used in other centers that do not have
access to algorithms featuring BAO. Dierent recipes for class solution generation were
explored. Erasmus-iCycle was used to generate 1060 plans for 30 patients.
In Chapter 4, non-coplanar robotic treatment with a CyberKnife was compared to copla-
nar Volumetric Modulated Arc Therapy (VMAT) on a regular C-arm linac. The CyberKnife
can easily deliver non-coplanar beams with high geometric precision due to tumor track-
ing, but at cost of increased treatment time. VMAT can oer fast coplanar treatments,
but target margins have to be increased due to the lack of tracking. Erasmus-iCycle was
coupled to both the CyberKnife and the VMAT clinical TPS to automatically generate cli-
nically deliverable prostate SBRT plans for the treatment technique comparisons.
The use of automated non-coplanar planning to increase plan quality for vestibular
schwannoma radiosurgery compared to manual planning was explored in Chapter 5. The
focus was on investigating whether autoplanning could reduce the dose bath in these
young patients with benign tumors, without losses in plan quality for the tumor or the
OARs, or increases in treatment time.
In Chapter 6, Erasmus-iCycle was used to compare 24 beam configuration approaches
for a challenging and anatomically highly heterogeneous group of mediastinal lym-
13
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phoma patients. The investigations included coplanar and non-coplanar approaches,
both using individualized beam configuration optimization and beam angle class solu-
tions. 600 plans were automatically generated for 25 patients.
Chapter 7 focused on investigating a new treatment approach, designated VMAT+, which
merges the benefits of fast VMAT treatments with those of non-coplanar beam arrange-
ments. This approach was used to develop the VMAT+CS treatment approach, combining
VMAT with a beam angle class solution (CS) consisting of two IMRT beams with fixed di-
rections. VMAT+CS plans were compared with VMAT and 30-beam non-coplanar IMRT. A
total of 740 plans was generated for 20 patients.
In Chapter 8, challenges and opportunities of automated planning with and without
BAO, and of the use of non-coplanar beam configurations are discussed. The chapter
finishes with an outlook on potential future research.
14
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Abstract
In a recent paper we have published a new algorithm, designated ‘iCycle’, for fully-
automated multi-criterial optimization of beam angles and intensity profiles. In this
study, we have used this algorithm to investigate the relationship between plan qua-
lity and the extent of the beam direction search space, i.e. the set of candidate beam
directions that may be selected for generating an optimal plan.
For a group of 10 prostate cancer patients, optimal IMRT plans were made for Stereo-
tactic Body Radiation Therapy (SBRT), mimicking High Dose Rate (HDR) brachytherapy
dosimetry. Plans were generated for 5 dierent beam direction input sets, a coplanar
set and four non-coplanar sets. For coplanar (CP) treatments, the search space consisted
of 72 orientations (5◦ separations). The non-coplanar CK-space contained all directions
available in the robotic CyberKnife treatment unit. The fully non-coplanar (F-NCP) set
facilitated the highest possible degree of freedom in selecting optimal directions. CK+
and CK++ were subsets of F-NCP to investigate some aspects of the CK-space. For each
input set, plans were generated with up to 30 selected beam directions.
Generated plans were clinically acceptable, according to an assessment of our clini-
cians. Convergence in plan quality occurred only after around 20 included beams. For
individual patients, variations in PTV dose delivery between the 5 generated plans were
minimal, as aimed for (average spread in V95: 0.4%). This allowed plan comparisons
based on organ at risk (OAR) doses, with the rectum considered most important. Plans
generated with the non-coplanar search spaces had improved OAR sparing compared to
the CP search space, especially for the rectum. OAR sparing was best with the F-NCP, with
reductions in rectum DMean, V40Gy, V60Gy and D2% compared to CP of 25%, 35%, 37%, and
8%, respectively. Reduced rectum sparing with the CK search space compared to F-NCP
could be largely compensated by expanding CK with beams with relatively large direc-
tion components along the superior-inferior axis (CK++). Addition of posterior beams
(CK++ → F-NCP) did not lead to further improvements in OAR sparing. Plans with 25
beams performed clearly better than 11-beam plans. For coplanar plans, an increase
from 11 to 25 involved beams resulted in reductions in rectum DMean, V40Gy, V60Gy and
D2% of 39%, 57%, 64%, and 13%, respectively.
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2.1 Introduction
SBRT involves hypofractionated delivery of high radiation doses and requires highly
conformal treatment plans and optimal geometrical precision in daily dose delivery [17].
Hypofractionation may result in a treatment benefit for prostate cancer, as the α/β ratio
could be as low as 1.5 [24, 54, 88, 119]. Several randomized studies have demonstrated
advantages of moderate hypofractionation in prostate cancer [7, 129, 134, 198].
Based on promising results with the strongly hypofractionated prostate HDR brachy-
therapy [39, 62], interest has grown in developing non-invasive external beam radio-
therapy (EBRT) techniques with as little as four fractions. Several of these studies were
based on the robotic CyberKnife treatment unit (Accuray, Inc) with its image-guided tu-
mour tracking technology and easy use of non-coplanar beams [5, 56, 56–58, 74, 80, 85,
87, 90, 172].
The impact of beam angle optimization on the quality of treatment plans has been
investigated in many studies [3, 135, 136, 184, 189, 196]. To our knowledge, very little is
known on the importance of the extent of the beam angle search space in computer
optimization of beam orientations, especially for non-coplanar techniques.
Computer optimization of beam angles has been investigated for many years in our in-
stitution [135, 184, 189, 196]. Most papers relate to 3D conformal techniques [135, 184, 196],
or to CyberKnife treatments with circular cones, [189]. Recently, we developed a new
algorithm, designated ‘iCycle’, [22], for multi-criterial optimization of beam angles and
IMRT fluence profiles. In this study we have used iCycle to investigate the importance
of the beam angle search space in computer optimization of prostate SBRT plans that
mimic HDR brachytherapy dose distributions. Plan comparisons were made for 5 dier-
ent search spaces, including one with only coplanar directions, and one with the orien-
tations available at the CyberKnife.
2.2 Material and Methods
2.2.1 Patients
Planning CT-scans of ten prostate cancer patients, previously treated in our institution
with the CyberKnife, were included in this study. Patients were treated with a dose of
38 Gy, delivered in 4 fractions with a dose distribution that resembled prostate HDR
brachytherapy. The CT-scan slice distances were 1.5 mm, the average scan length was
19
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47.4 ± 6.7 cm (range: 35.7-55.7 cm). PTVs included the entire delineated GTV plus a 3 mm
margin. The average volume was 90.8 ± 23.1 cc (range: 69.5-145.4 cc). Within the GTV, the
peripheral zone (PZ) was defined with the help of MR-images. Patients had 4 implanted
markers for image guidance and were treated supine with their feet towards the robotic
manipulator.
2.2.2 iCycle
All treatment plans were generated with iCycle, our novel in-house developed algo-
rithm for automated, multi-criterial optimization of beam angles and IMRT fluence pro-
files. The algorithm is described in detail in [22]. Here a brief summary of its features is
provided.
Fully-automated plan generation with iCycle is based on a ‘wish-list’, defining hard
constraints that are strictly met and prioritised objectives [23]. The higher the priority
of an objective, the higher the chance that the goal will be approached closely, reached
or even exceeded. Furthermore, a list of candidate beam orientations for inclusion in the
plan is needed. The beam direction search spaces and wish-list used in this study are
described in detail below in the sections 2.2.3 and 2.2.4, respectively. A plan generation
starts with zero beams. Optimal directions are sequentially added to the plan in an
iterative procedure, up to a user-defined maximum number of beams. After each beam
addition, iCycle generates a Pareto optimal IMRT plan including the beam directions
selected so far. Consequently, plan generation for a patient always results in a series
of Pareto optimal plans with increasing numbers of beams. For example, in this study
the selected maximum number of beams is 30, resulting for each case in Pareto optimal
IMRT plans with 30, 29, 28, 27, . . . beams. By design, addition of a beam improves plan
quality regarding the highest prioritized objective that can still be improved on [22].
2.2.3 Investigated beam direction input sets (search spaces)
In this study, the isocentre was placed in the centre of the tumour. Beam directions
were defined by straight lines (beam axes) connecting the isocentre with focal spot po-
sitions situated on a sphere centred around the isocentre. The five investigated beam
direction search spaces were defined as follows:
1. CP (coplanar): 72 equi-angular orientations in the axial plane through the isocen-
tre, covering 360◦ around the patients (angular separation 5◦).
2. CK (used by the CyberKnife robotic treatment unit): graphical presentation shown
in figure 2.1. The set consists of 117 directions. Interesting features are the absence
20
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Figure 2.1: CyberKnife (CK) search space. Dots represent focal spot positions.
of beams with a large posterior component (right upper panel in figure 2.1: avail-
able directions in the axial plane are limited to [-110◦,110◦]), and the asymmetry
in the beam direction set (left lower panel in figure 2.1) related to the asymmetric
position of the robotic manipulator relative to the treatment couch.
3. F-NCP (fully non-coplanar): largest set of all 5, theoretical, i.e. not related to a
particular treatment device. Ideally, it should represent the search space as de-
fined by all focal spots on a complete sphere around the isocentre. In the axial
plane, through the isocentre, the angular distance between directions is 5◦ (F-NCP
includes CP). Non-coplanar directions are separated by 10◦. However, iCycle re-
moves the non-coplanar treatment beams that enter (partially) through the end
of the CT dataset, which limits the available number of beam directions due to
the finite lengths of the CT data sets (sect. 2.2.1). Because of this limitation, the
maximum deviation from the AP-axis in the sagittal plane is around 55◦. F-NCP
includes around 500 beam orientations, depending on the patient.
4. CK++: as F-NCP, however excluding (only) directions with a posterior component
21
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outside the borders of the CK search space. In the axial plane this results in ex-
clusion of beams outside the [-110◦,110◦] range (figure 2.1, upper right panel). De-
pending on the patient, CK++ has around 300 beam directions.
5. CK+: as F-NCP, however excluding all directions outside the borders of the CK
search space (figure 2.1). Because of the higher focal spot density, the number of
available directions in CK+ is higher than for CK, i.e. 186 vs. 117.
2.2.4 iCycle generation of prostate SBRT plans
iCycle was used to optimize beam angles and intensity profiles for high quality SBRT
plans, mimicking HDR brachytherapy dose distributions. Table 2.1 shows the applied
wish-list with planning constraints and objectives in the upper and lower parts, respec-
tively. The wish-list was established in a trial-and-error procedure to ensure for this
patient population, generation of high quality plans with the desired balance between
the clinical objectives (see also [22, 184]). Most important clinical goals were adequate
PTV coverage and a maximally reduced rectum dose.
The two highest priority objectives, defined with Logarithmic Tumour Control Probabil-
ity (LTCP) functions [1] aimed at adequate PTV dose delivery. The first focused on control
of PTV doses around 34-38 Gy, while the second mainly steered PTV doses around 55-60.8
Gy. For each patient, the goal was to generate, for all 5 beam angle search spaces (sect.
2.2.3), plans with highly similar PTV dose delivery, all close to the dose delivered in the
clinical plan, allowing comparison of search spaces based on OAR plan parameters. To
this purpose, prior to the final plan generations for a patient, trial plans were generated
to fine-tune the LTCP sucient and α parameters [21] for a PTV maximum dose constraint
(table 2.1) equal to the maximum dose in the clinical plan. For each patient, a fixed set
of sucient, α , and PTV maximum dose values was used for the final plan generation
for all five search spaces.
As in clinical practice, reduction of rectum dose delivery was the most important OAR
objective (priority 3 in table 2.1), aiming at a mean dose of 0 Gy. With this choice, the
optimizer would only reduce doses to other OARs to the extent that this would not com-
promise reaching the lowest possible mean rectum dose. Other OAR considered with
lower priorities were urethra, bladder, penis, scrotum and femoral heads. Other struc-
tures, Rings, were defined to control and reduce the dose to healthy tissues: ‘Ring 1’
includes all tissue between 2 and 3 cm from the PTV, ‘Ring 2’ was all tissue between the
body contour and the body contour-2cm and ‘Ring 3’ referred to all tissue in between
Ring 1 and Ring 2. Hard constraints on Ring 1 and Ring 2 had to enforce a steep dose
fall-o outside the target and to limit the entrance dose, respectively. The priority 7
objective on Ring 3 aimed at dose reduction to healthy tissues, also if not part of an
22
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OAR.
For all beam direction search spaces considered in this study, the simulations assumed
that beam collimation was performed with a dynamic multi-leaf collimator (MLC) with a
5 mm leaf width. Maximum field size was 10×12 cm2 and leaves had full interdigitation
and overtravel. For dose calculations, percentual depth dose curves and profiles of an
Elekta Synergy 6MV beam, collimated with an MLCi2, were used. Pencil beam kernels for
optimization were derived as described in [164]. Equivalent path length correction was
used for inhomogeneity correction.
Constraints
Structure Type Limit
PTV maximum 59-69 Gy
Rectum maximum 38 Gy
Urethra maximum 40 Gy
Bladder maximum 41.8 Gy
Penis Scrotum maximum 4 Gy
Penis Scrotum mean 2 Gy
Ring 2 maximum 15 Gy
Ring 1 maximum 20 Gy
Objectives Parameters
Priority Structure Type Goal (Dp , α , sucient)
1 PTV LTCP 1 (34-38 Gy, 0.7, 0.003-0.20)
2 PTV LTCP 4 (55-60.8 Gy, 0.1-0.2, 4-26)
3 Rectum mean 0 Gy
4 PZ LTCP 1 (45 Gy, 0.9)
5 Urethra mean 0 Gy
6 Bladder mean 0 Gy
7 Ring 3 maximum 15 Gy
8 Rectum maximum 30 Gy
9 Bladder maximum 35 Gy
10 Penis Scrotum maximum 0
11 L and R Femur head maximum 24
Table 2.1: Applied wish-list for all study patients. For definition of Ring 1, 2 and 3 see sect. 2.2.4.
2.2.5 Details on plan evaluation and comparison
The plans in this study were evaluated by a clinician (SA) to check clinical acceptability.
In accordance with the ICRU-83 report [105], D2% and D98% were reported instead of
maximum and minimum doses, respectively. In line with QUANTEC findings [117], rectum
dose delivery reporting included V40Gy and V60Gy, calculated by first converting delivered
doses to a 2 Gy/fraction regime using an alpha/beta parameter of 3 Gy. Apart from doses
23
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delivered to the PTV, PZ and OARs, we also analyzed V10Gy, V20Gy, and V30Gy, the patient
volumes receiving more than 10, 20, and 30 Gy, respectively. Evaluations also included
the conformity index (CI) calculated as the ratio of the total tissue volume receiving 38
Gy or more and the PTV (almost 100% of the PTV received 38 Gy, see Results section).
Hard constraints on dose delivery to the penis and the scrotum guaranteed negligible
doses to these structures in all plans (table 2.1), which are not reported in the Results
section.
As described in section 2.4, for each patient we aimed at highly similar PTV doses for
all five search spaces. In the Results section it is demonstrated that dierences were
indeed very small. For this reason comparison of plans and search spaces could be
based on doses delivered to healthy tissues with the rectum being the most important
one. The two-sided Wilcoxon signed-rank test was used to compare plan parameters in
the various search spaces. A p-value of <0.05 was defined as statistically significant.
2.2.6 Treatment time calculation for the CK search space
We calculated treatment times for the hypothetical situation that the CyberKnife would
be equipped with an MLC. Treatment times consist of beam-on time, linac travel time,
and imaging time. For calculation of beam-on times, we used a leaf sequencing algo-
rithm described in [148], assuming a linac output of 1000 MU/min (as available for the
current CyberKnife), a maximum leaf speed of 2.5 cm/s and full leaf interdigitation and
overtravel (see also section 2.2.4). Leaf synchronization was not applied. The linac travel
time is the time to travel through all selected focal spot positions. However, CyberKnife
movements are not totally free, i.e. it can not freely travel from each spot position to
any other, but it sometimes has to pass unselected (but allowed, figure 2.1) positions to
reach a next selected position. The applied travel time calculation algorithm selects the
shortest path, considering all possible movements between spot positions [189]. For the
treatment time calculations, we assumed that prior to dose delivery from a focal spot
position, images were acquired to verify, and if needed, correct alignment of the beam
to be delivered with the current tumour position. Imaging time takes only 2 seconds.
However, CK has some node positions from which it is not possible to take an image. To
handle this, the machine has to travel to the nearest node position from which imaging
is allowed and come back to the delivery position. This aspect was also considered in
the calculation of the treatment times.
24
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2.3 Results
2.3.1 Generated plans
In this section, plans and analyses performed for the first study patient are described
in some detail to provide examples of the investigations performed for all 10 patients.
Figure 2.2 shows an axial dose distribution for the 25-beam plan generated with the
CK search space. Clearly visible are the high degree of rectum sparing, the reduced dose
in the urethra, and the increased dose in the peripheral zone (PZ), as enforced by the
applied wish-list (table 2.1).
Figure 2.2: Axial dose distribution for the 25-beam plan generated with the CK search space for the first study
patient. For definition of Ring 1 see sect. 2.2.4.
Figure 2.3 shows DVHs for the 25-beam plans generated with each of the 5 search
spaces in this study. As aimed for (sect. 2.2.4), PTV coverages for the 5 plans were highly
similar (upper left zoom). Rectum sparing was best for F-NCP and CK++, while for the
coplanar (CP) plan, rectum dose was clearly highest (lower left zoom). F-NCP was best
for bladder and CK++ for urethra, with F-NCP second. Obviously, plans for the the non-
coplanar search spaces with the largest extents (F-NCP and CK++) were most favorable
for this patient.
Figure 2.4 shows plan parameters as a function of the number of beams in the plan.
For all beam numbers, PTV coverage was very similar for the 5 search spaces. The second
row shows that for all search spaces, rectum dose parameters improved with increasing
numbers of beams, with some levelling o between 15-20 beams. Also bladder DMean,
urethra DMean, V10Gy, V20Gy, and V30Gy improved with increasing numbers of beams. A
very similar behavior of plan quality on numbers of involved beams was seen for all 10
25
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Figure 2.3: DVH comparison for patient 1 for five 25-beam plans, each generated for one of the five studied
search spaces.
patients in this study. In the next section, population data will be provided for PTV and
rectum.
2.3.2 Plan quality vs number of beams in plans, PTV and rectum
The left panel in figure 2.5 shows the average PTV V95 and PTV D98 for the 10 study pa-
tients, as a function of the number of beams in the plans, normalized to the CP 10-beam
plan. For each search space, these quantities are largely independent of the number
of beams (normalized values dier up to 0.8% and 2% for average PTV V95 and D98, re-
spectively). The trend to slightly reduced PTV dose delivery with increasing number of
beams is (partly) related to enhanced urethra sparing with more beams (no data pre-
sented). For all beam numbers, these PTV dose parameters are also highly similar for
the 5 search spaces with variations up to less then 0.5%. The right panel demonstrates
substantial dierences between the search spaces in population averaged rectum DMean
and rectum V60Gy, with lowest values for F-NCP and least favorable values for CP. For
20 beams, F-NCP averaged rectum DMean and V60Gy were 29% and 45% lower compared
to CP. For all 5 search spaces, rectum dose improved with increasing number of beams.
None of the curves in the right panel fully levels o, but reductions with beam number
are clearly most prominent up to around 20 beams. In the remainder of this paper, data
for 25-beam plans will be reported, unless stated otherwise.
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Figure 2.4: Dosimetrical results for patient 1 for plans with 10 up to 30 beams for the 5 studied input beam
sets.
2.3.3 25-beam plans - Coplanar (CP) vs non-coplanar beam direction
search spaces
Table 2.2 provides a comparison of the CP search space with the four non-coplanar
spaces regarding plan parameters of the generated 25-beam plans.
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Figure 2.5: Population averaged PTV (left) and rectum (right) plan parameters as function of beam number,
for 10-30 beam plans. All percentages are relative to absolute population mean values of the CP 10-beam
plan, i.e. PTV V95=99.5%, PTV D98=37.8 Gy, Rectum DMean=11.3 Gy and Rectum V60Gy=8%.
As aimed for (sect. 2.2.4), dierences in PTV DMean, PTV V95 and PTV D98% between the
5 search spaces were clinically and/or statistically insignificant. Compared to CP, only
PTV D2% was around 3% higher for non-coplanar set-ups (p<0.05), but clinically these
increases were considered unimportant. No relevant dierences were observed in the PZ
parameters. Because of this high similarity in target dose for the 5 search spaces, in the
remainder of this paper, plan comparisons are focused on organs at risk and especially
on the rectum.
The rectum population mean plan parameters were clearly lowest for the 4 non-coplanar
search spaces (table 2.2). For the largest search space, F-NCP, population mean reduc-
tions relative to CP in rectum DMean, V40Gy, V60Gy, and D2% were as large as 25.0%, 34.9%,
36.5%, and 7.5%, respectively. For CK, these reductions were smallest but still highly
relevant (18.5%, 23.2%, 21.4% and 3.9%, respectively). Figure 2.6 demonstrates that the
superiority of the non-coplanar search spaces holds for all individual patients. Patient 7
had the highest CP rectum dose parameters, while percentual reductions with the non-
coplanar set-ups were also highest (figure 2.6). Regression analyses showed, for all
4 non-coplanar search spaces, increasing percentual reductions in rectum dose para-
meters for increasing CP parameters (p=0.001-0.03), i.e. patients with less favorable CP
rectum parameters had largest reductions when switching to a non-coplanar plan.
Population mean urethra doses were equal for all 5 search spaces (table 2.2). Dier-
ences between non-coplanar spaces and CP in mean bladder dose were highly patient
specific. F-NCP and CK++ had on average ≈9% lower mean bladder doses, while for CK+
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Figure 2.6: Comparison of the CP search space with the four non-coplanar spaces for four rectum plan
parameters. On the right of each panel, the CP absolute values for each patient are reported. The four
columns on the left report the percentage dierences for non-coplanar search spaces with the CP plan. For
all patients and all parameters, dierences ∆[%] are below zero, showing the improved rectum sparing with
non-coplanar beam search spaces. All plans are with 25 beams.
and CK, mean bladder doses were around ≈11% higher compared to CP. None of these
dierences were statistically significant. With CP, doses in the femoral heads were al-
ready low, but substantial percentual reductions were seen for the non-coplanar beam
sets. Also V10Gy and V20Gy were lowest for the non-coplanar sets.
V30Gy, the total delivered number of MU and the conformity index (CI) were the only
parameters for which CP plans did on average (slightly) better than non-coplanar set-
ups. V30Gy and MU were 3-5% and 8% lower in the CP plans. The mean CI in the CP plans
for the 10 study patients was 1.2, which increased to 1.27-1.31 for the non-coplanar sets.
2.3.4 25-beam plans - Comparison of non-coplanar search spaces
As described in detail in section 2.2.3, non-coplanar search spaces increased in ex-
tent when going from CK to CK+ to CK++ and finally to F-NCP. Briefly, CK+ had the same
boundaries as CK but a higher spot density, CK++ was an expansion of CK+ with beams
with relatively large direction components along the superior-inferior axis and F-NCP
was an extension of CK++, making it the only non-coplanar search space with posterior
beams. In this section, changes in plan parameters related to these increases in degree
of freedom for selecting optimal non-coplanar beam angles are discussed.
CK→ CK+ As also visible in table 2.2, CK has the highest mean rectum dose parameters
of the 4 non-coplanar beam direction search spaces. Increasing the focal spot density
did only marginally improve rectum dose delivery, although reductions in DMean of 2.2%
and in V40Gy of 3.2% were statistically significant. For urethra and bladder, dierences in
delivered dose were negligible (table 2.2). Significant dierences were found for femoral
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head doses. With CK+, DMean and D2% for right and left head decreased by 15%, 9%, 11%
and 10%, respectively (p-values: 0.02, 0.04, 0.04, 0.03). Small, but statistically signi-
ficant, dierences were found for V20Gy (CK+ 1% lower, p=0.01), V30Gy (CK+ 1.1% higher,
p=0.02), and for CI (CK+ 1.5% higher, p=0.01).
CK+→ CK++ With this increase in search space, population mean rectum DMean, V40Gy,
V60Gy and D2% were reduced by as much as 6.8%, 12.0%, 16.9%, and 3.5%, respectively
(p=0.002). Large improvement was also found for the bladder with a reduction in DMean
of 26.9% (p=0.01). V20Gy was also improved with CK++ (1.7%, p=0.002). CI was slightly
better for CK+ (2.3%, p=0.001).
CK++→ F-NCP Adding posterior beams by going from CK++ to F-NCP did not result in
relevant further reductions in rectum dose (table 2.2). Very small improvements were
seen for V20Gy (1.5%, p=0.006), V30Gy (1.6%, p=0.001), and CI (2.0%, p=0.004).
2.3.5 25-beam plans - Distribution of selected beam orientations
Figure 2.7 shows selected beam directions for the 25-beam F-NCP plan of each indivi-
dual study patient. Clearly, there is a preference for beams with a large lateral compo-
nent. Comparison of the right panels of figures 2.7 and 2.8 shows that most high-weight
beams in the F-NCP plans are within the CK++ search space. Apparently, beams with a
large posterior component are not frequently selected or have low weights.
2.3.6 25-beam plans - Treatment times for the CK search space
Treatment times for the 25-beam CK plans were on average 18.1±0.5 minutes, including
dose delivery, robot motion and imaging and set-up correction prior to delivery of each
beam (section 2.2.6).
2.3.7 11 vs 25-beam coplanar plans
As visible in figure 2.4 for patient 1 and in the right panel of figure 2.5 for the patient
population, OAR plan parameters may substantially improve with increasing numbers
of beams in the plans. On regular treatment units, IMRT plans are generally delivered
with coplanar beam set-ups with ≤11 beams. Table 2.3 compares coplanar plans with
11 and 25 beams. Although dierences in PTV parameters are statistically significant,
they are small, and clinically the obtained PTV doses are considered highly comparable.
An important consideration here is that the dierence in PTV V95, our most important
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parameter for PTV dose evaluation, is very small. The most striking dierences were
found for the rectum with improvements in DMean, V40Gy, V60Gy and D2% of 39.2%, 57%,
63.7%, and 12.6% (p=0.002), when increasing the number of beams from 11 to 25. Bladder
DMean and D2% reduced by 14.4% (p=0.002) and 5.3% (p=0.004), respectively, and V10Gy
improved by 11.1% (p=0.002). When switching to 25-beam plans, the MU increased on
average by 75.7% (p=0.002).
Figure 2.7: Selected focal spots/beams by iCycle for 25-beam F-NCP plans for all 10 patients in a 3D (left) and
an axial view (right). Colours refer to dierent patients, beam weights are proportional to the dot diameters.
Figure 2.8: Selected focal spots/beams by iCycle for 25-beam CK++ plans for all 10 patients in a 3D (left) and
an axial view (right). Colours refer to dierent patients, beam weights are proportional to the dot diameters.
2.3.8 Calculation times
iCycle simulations were done in Matlab 7.12, R2011a, The Mathworks Inc., on a 4 socket
10-core Intel Xeon E7. Plan optimization required ≈35 hours to generate for one patient
F-NCP plans with up to 25 beams, i.e. 25 complete plans have been generated and all
data are individually available, and around ≈45 hours for up to 30 beams. These times
reduced to ≈15 and ≈25 hours to generate coplanar treatment plans.
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11 beams, CP 25 vs 11 beams, CP (%)
Mean ± 1SD [Range] ∆Mean ± 1SD [Range] p-value
Target
PTV DMean 45.1 ± 1.0 (Gy) [43.4,46.7] 3.4 ± 3.1 [0.2,9.1] .002
PTV V95 99.4 ± 0.4 (%) [98.7,99.9] -0.5 ± 0.5 [-1.8,0.3] .01
PTV D98% 37.8 ± 0.5 (Gy) [37.1,38.6] -1.5 ± 1.4 [-3.9,1.6] .02
PTV D2% 52.8 ± 1.8(Gy) [49.5,56.1] 7.0 ± 4.2 [1.6,13.2] .002
PZ DMean 48.1 ± 0.9 (Gy) [46.5,48.9] 4.6 ± 4.5 [-0.8,11.5] .006
PZ D98% 42.5 ± 1.0 (Gy) [39.8,43.3] -12.4 ± 2.8 [-16.4,-5.4] .002
Rectum
DMean 10.2 ± 2.9 (Gy) [5.5,13.7] -39.2 ± 9.0 [-48.0,-18.6] .002
V40Gy 15.2 ± 4.9 (%) [7.8,22.2] -57.0 ± 9.2 [-63.3,-34.3] .002
V60Gy 6.5 ± 2.4 (%) [3.2,10.9] -63.7 ± 9.3 [-78.1,-46.9] .002
D2% 33.7 ± 1.5 (Gy) [31.3,35.4] -12.6 ± 4.2 [-19.0,-7.4] .002
Urethra
DMean 33.1 ± 3.3 (Gy) [27.5,36.9] -2.6 ± 1.2 [-4.7,-0.9] .002
D2% 40.0 ± 0.2 (Gy) [39.7,40.5] -0.2 ± 0.5 [-1.2,0.7] NS
Bladder
DMean 10.2 ± 2.3 (Gy) [5.1,13.7] -14.4 ± 9.1 [-28.1,-2.5] .002
D2% 36.3 ± 3.0 (Gy) [27.9,37.9] -5.3 ± 3.7 [-9.8,0.6] .004
Femural Heads
R DMean 7.8 ± 2.5 (Gy) [4.7,12.3] 19.9 ± 30.1 [-14.0,92.1] NS
R D2% 15.3 ± 2.0 (Gy) [12.9,18.4] 3.5 ± 13.0 [-11.0,27.4] NS
L DMean 8.0 ± 1.7 (Gy) [6.0,10.8] 12.7 ± 17.3 [-19.5,44.5] .03
L D2% 15.2 ± 1.3 (Gy) [13.8,17.3] 2.0 ± 8.7 [-12.2,12.5] NS
Other
V10Gy ∗ 2274 ± 382 (cc) [1824,3163] -11.1 ± 2.6 [-15.2,-6.9] .002
V20Gy ∗ 365 ± 67 (cc) [295,520] -3.4 ± 2.7 [-7.4,2.2] .006
V30Gy ∗ 178 ± 33 (cc) [143,257] -4.8 ± 3.0 [-9.4,0.2] .004
CI 1.2 ± 0.1 [1.1,1.3] -2.5 ± 4.5 [-10.0,3.1] NS
MU 24791 ± 1302 [22624,26844] 75.7 ± 9.2 [56.8,91.7] .002
Table 2.3: Results for 10 patients for 11 and 25 coplanar beam plans. The first column reports the results
obtained with the 11 beam coplanar configuration. In the next columns, the percentage decrease from the 11
beams CP results are shown. (∗) refers to all tissues receiving >10, >20 or >30 Gy.
2.4 Discussion
Recently, we have presented iCycle, our in-house developed algorithm for integrated,
multicriterial optimization of beam angles and profiles [22]. For plan generation, iCycle
uses a priori defined plan criteria (wish-list, section 2.2.4 and table 2.1) and a beam di-
rection search space. The wish-list is used to fully automatically generate high quality
plans without interactive tweaking of parameters such as weighting factors in the cost
function. For a plan with N selected orientations, the solution is Pareto optimal regard-
ing the generated beam profiles [21, 22]. To ensure generation of clinically acceptable
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plans with favourable balances in the outcomes for the various plan objectives, wish-
lists are developed in close collaboration with treating clinicians. This study is based on
1500 treatment plans generated with iCycle (10 patients, 5 beam sets, 30 beams). Due
to the automation, the plan generation workload was minimal and plan quality was in-
dependent of the experience and skills of human planners. To our knowledge, this is
the first paper investigating in details the impact of the extent of the beam angle search
space in computer optimization of IMRT dose distributions.
For each individual patient, PTV doses in the iCycle generated plans for the five inve-
stigated search spaces were highly similar (figures 2.3, 2.4, 2.5 and table 2.2), and tuned
to be in close agreement with the clinically delivered dose. This allowed focusing plan
comparisons on OARs, and specifically on the highest priority OAR, the rectum. Rectum
doses for all four non-coplanar beam direction search spaces were clearly superior when
compared to doses obtained with the coplanar search space (figures 2.3, 2.4, 2.5, 2.6 and
table 2.2). Also for the femoral heads, V10Gy and V30Gy, non-coplanar plans performed
better (table 2.2). Coplanar plans had (slightly) improved V30Gy, CI and MU.
The CK+ and CK++ search spaces were used to study dosimetrical consequences of
limitations in the extent of the CK space (figure 2.1, sections 2.2.3, 2.3.4 and 2.3.5). The
data presented in section 2.3.4 do clearly demonstrate that extension of the CK space to
include beams with larger direction components along the superior-inferior axis could
substantially enhance plan quality (CK+→ CK++). On the other hand, further addition of
beams with larger posterior components did not improve plans (CK++→ F-NCP). Com-
parison of the right panels in figures 2.7 and 2.8 shows that also in case of availability of
the posterior beams (F-NCP), most selected high-weight beams are within the borders of
the CK++ space that lacks posterior beams. As plan quality for F-NCP and CK++ is highly
similar, it may be concluded that omission of posterior beams does not limit the quality
of generated plans.
As demonstrated in figures 2.4 and 2.5, for all search spaces, plan quality continued
to improve with increasing numbers of involved beams, with some levelling o for >20
beams. Table 2.3 details the very significant improvements that can be obtained with 25
coplanar beam configurations compared to 11 coplanar beams. This observation might
seem in striking contrast with the broadly applied ≤9 beams for prostate in clinical
practices. However, it has to be considered here that HDR like dose distributions were
investigated in this paper, aiming at highly inhomogeneous PTV doses with some sparing
of the urethra and enhanced dose delivery in the peripheral zone. In an on-going study
we are investigating the use of large numbers of beams for more regular prostate IMRT
dose distributions.
Also for very large beam numbers, non-coplanar configurations performed clearly bet-
ter than coplanar set-ups (figures 2.5, 2.6, table 2.2). On conventional treatment units
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with L-shaped gantries, delivery of non-coplanar plans with many beams would result
in impractically long treatment times and a high workload because of the involved couch
rotations. The latter would also limit treatment accuracy. The performed treatment time
calculations for a robotic CyberKnife equipped with an MLC (sections 2.2.6 and 2.3.6)
demonstrated that treatment times of around 18 minutes could be obtained with such
a system, including intra-fraction imaging and position correction prior to delivery of
each of the 25 beams.
As mentioned in section 2.2.4, for each patient, PTV doses in iCycle plans were highly
similar to the dose in the plan generated with the clinical treatment planning system for
actual treatment with the CyberKnife. On the other hand, it was observed that rectum
doses in iCycle plans were highly superior to corresponding doses in the clinical plans
(not described in detail in this paper). This may seem unexpected for the CK search
space that contains the feasible beam directions of the CyberKnife treatment unit. A
possible explanation may be that clinical plans were generated with 3 circular cones
per patient, while for the iCycle simulations it was assumed that beam collimation was
performed with an MLC. These observations are now being investigated in great detail,
to be reported in a separate paper.
In this study, minimization of the mean rectum dose was used as the highest prior-
ity objective, aiming at rectum sparing (table 2.1). Many studies have been performed
to establish plan parameters that correlate most with rectum toxicity, see [117] for an
overview. The QUANTEC group suggests V60, but using this objective directly in the op-
timization leads to less desirable results because of the focus on a single dose-point.
Instead we used rectum DMean as an objective in the optimizations, whileV60 was in-
cluded in plan evaluations.
In iCycle, the wish-list is used to generate plans with favourable balances between
the various treatment goals. In our investigations we imposed a very strong drive for
minimization of the mean rectum dose (table 2.1: priority 3, Goal: 0 Gy). Such a fo-
cus on rectum dose minimization has a danger that slightly higher rectum doses could
potentially result in (unobserved) much improved doses to other OAR. In the trial plan
generations for creating the applied wish-list (section 2.2.4), no evidence was found that
this would actually occur. In the near future, we will however study the value of naviga-
tion tools [33, 120, 167] for exploring the solution space around iCycle generated plans.
Anyway, as in this study the same wish-list was used for all search spaces, numbers of
involved beams and patients, it is believed that the impact of not performing navigation
on main conclusions of the work will be minimal.
In this paper we compared plan quality of treatments with up to 30 optimized coplanar
beam directions with optimized non-coplanar techniques. There is no existing machine
that can deliver treatments for all investigated beam search spaces. The CyberKnife
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search space does not include 72 equi-angular coplanar beams, neither does it contain
all directions defined for CK+ and CK++. The fully non-coplanar (F-NCP) space cannot be
realized with any of the commercially available systems, e.g. because of linac-bunker
floor collisions, gantry-couch collisions, or beams going through heavy couch elements.
However, the F-NCP dose distributions give an upper limit of what could theoretically be
obtained with optimized non-coplanar set-ups. To make conclusions on the impact of
the beam search space on plan quality independent of the applied optimizer, the type
of beam shaping, and the beam characteristics, all optimizations were performed with
the iCycle optimizer, using the same dose calculation engine for the same MLC (section
2.2.4).
Optimization results may depend on dose calculation accuracy [77]. It is well known
that dose calculations using pencil beams and equivalent path length correction have
limited accuracy, especially in low density tissues. In this study on prostate cancer, these
tissues were largely absent in the treatment fields. Moreover, the same dose calculation
algorithm was used for all beam direction search spaces. Therefore, we believe that li-
mitations in the applied dose calculation engine do not jeopardize our main conclusions
on ranking of the beam search spaces.
As described in section 2.3.8, optimization times were long, especially for the largest
non-coplanar search spaces. There are many possibilities for substantial reductions
and this is an area of active research in our group. On the other hand, based on an
a priori defined, fixed wish-list per patient group, iCycle optimized plans are generally
of very high quality, and do not require further iterations with new iCycle runs [22] (as
explained in section 2.2.4, in this study, PTV constraints and objectives were tuned per
patient to reproduce dierent clinical PTV dose distributions). In a recent prospective
clinical study for evaluation of iCycle in head and neck IMRT, for each patient the treating
physician was presented a plan based on iCycle and a plan made by dosimetrists with the
clinical treatment planning system. In 32 out of 33 plan selections, the treating physician
selected the iCycle based plan. Also objectively, the latter plans were clearly of higher
quality [186].
This study focused on generation of prostate SBRT plans that mimicked HDR brachy-
therapy dose distributions. Conclusions on the importance of non-coplanar beams, on
the favorable use of large numbers of beams (>20), and on the limited importance of
posterior beams may not be valid in other circumstances. Recently, we demonstrated for
a group of head and neck cancer patients that inclusion of non-coplanar beams in the
search space did only marginally improve IMRT plans [184]. Studies for other treatment
sites are on-going.
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2.5 Conclusion
For prostate SBRT, IMRT plans generated with all four investigated non-coplanar search
spaces had clearly improved organ at risk (OAR) sparing compared to the coplanar (CP)
search space, especially for the rectum which was the most important OAR in this study.
OAR sparing was best with the fully non-coplanar search space (F-NCP), with improve-
ments in rectum DMean, V40Gy, V60Gy and D2% compared to CP of 25%, 35%, 37%, and 8%,
respectively. Reduced rectum sparing with the CyberKnife (CK) search space compared to
F-NCP could be largely compensated by extending the CK space with beams with relati-
vely large direction components along the superior-inferior axis (CK++). Further addition
of posterior beams to define the F-NCP search space, did not result in plans with clini-
cally relevant further reductions in OAR sparing. Plans with 25 beams performed clearly
better than plans with only 11 beams. For coplanar set-ups, an increase in involved num-
ber of beams from 11 to 25 resulted in reductions in rectum DMean, V40Gy, V60Gy and D2%
of 39%, 57%, 64%, and 13%, respectively.
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Abstract
Purpose: To investigate development of a recipe for the creation of a beam angle class
solution (CS) for noncoplanar prostate stereotactic body radiation therapy to replace
time-consuming individualized beam angle selection (iBAS) without significant loss in
plan quality, using the in-house ”Erasmus-iCycle” optimizer for fully automated beam
profile optimization and iBAS.
Methods and Materials: For 30 patients, Erasmus-iCycle was first used to generate
15-, 20-, and 25-beam iBAS plans for a CyberKnife equipped with a multileaf collimator.
With these plans, 6 recipes for creation of beam angle CSs were investigated. Plans of 10
patients were used to create CSs based on the recipes, and the other 20 to independently
test them. For these tests, Erasmus-iCycle was also used to generate intensity modulated
radiation therapy plans for the fixed CS beam setups.
Results: Of the tested recipes for CS creation, only 1 resulted in 15-, 20-, and 25-beam
noncoplanar CSs without plan deterioration compared with iBAS. For the patient group,
mean dierences in rectum D1cc, V60GyEq, V40GyEq, and Dmean between 25-beam CS
plans and 25-beam plans generated with iBAS were 0.2 ± 0.4 Gy, 0.1% ± 0.2%, 0.2% ±
0.3%, and 0.1 ± 0.2 Gy, respectively. Dierences between 15- and 20-beam CS and iBAS
plans were also negligible. Plan quality for CS plans relative to iBAS plans was also pre-
served when narrower planning target volume margins were arranged and when plan-
ning target volume dose inhomogeneity was decreased. Using a CS instead of iBAS re-
duced the computation time by a factor of 14 to 25, mainly depending on beam number,
without loss in plan quality.
Conclusions: A recipe for creation of robust beam angle CSs for robotic prostate stereo-
tactic body radiation therapy has been developed. Compared with iBAS, computation
times decreased by a factor 14 to 25. The use of a CS may avoid long planning times
without losses in plan quality.
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3.1 Introduction
Several reports have suggested a benefit for stereotactic body radiation therapy (SBRT)
for patients with prostate cancer [7, 24, 87, 134, 198]. The robotic CyberKnife (Accuray Inc,
Sunnyvale, CA) may be used for easy delivery of noncoplanar beams and for image-
guided tumor tracking based on implanted fiducials [6, 14, 55, 57, 74, 80, 81, 89, 90].
In clinical practice, development of a high-quality noncoplanar plan may be a lengthy
procedure. Moreover, the common trial-and-error tweaking of treatment planning sys-
tem (TPS) parameters by dosimetrists to steer the TPS toward an acceptable solution
results in a plan quality that may heavily depend on the skills and experience of the
dosimetrist.
Several studies have shown potential benefit of automatic treatment planning [19, 22,
68, 98, 100, 101, 185, 186, 197, 199]. In our institution, the Erasmus-iCycle TPS has been de-
veloped for fully automated multicriteria optimization of beam profiles (intensity modu-
lated radiation therapy, IMRT) and individualized beam angle selection (iBAS) [22]. Each
Erasmus-iCycle plan generation for an individual patient is based on a treatment site–
specific ”wishlist” with hard constraints and prioritized objectives, established a priori in
collaboration with treating physicians to ensure generation of clinically desired, Pareto
optimal IMRT plans [68, 98, 135, 143, 184–186].
In a prospective clinical study on head and neck cancer, we demonstrated that IMRT
plans generated using Erasmus-iCycle were superior to ”manually” generated plans in
the clinical routine; in 97% of cases the treating physician selected the Erasmus-iCycle–
based plan for patient treatment [186]. For prostate cancer, automatically generated
volumetric modulated arc therapy plans were as good as plans generated by an expert
planner spending up to 4 hours’ hands-on time on tweaking of TPS parameters [185].
Our clinical head and neck cancer, cervix cancer, and prostate cancer plans are currently
generated fully automatically using Erasmus-iCycle [68].
The proven high plan quality together with the avoidance of both workload and opera-
tor dependency make the Erasmus-iCycle an interesting tool for objective comparisons
of treatment strategies based on planning studies with a large number of plans. Re-
cently, the Erasmus-iCycle was used in various studies: (1) to systematically investigate
the impact of beam number and noncoplanar beam setups in head-and-neck cancer
IMRT [184]; (2) to compare treatment strategies for prostate cancer patients with hip
prostheses [186]; and (3) to investigate the beam direction search space in prostate
SBRT, mimicking high-dose rate brachytherapy dosimetry, as used in our clinical prac-
tice [143]. In the latter study, coplanar and noncoplanar IMRT treatments with up to 30
beams were investigated. For both, improvements in plan quality obtained by adding
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(computer-selected) beam directions only started to level o after 20 beams. Noncopla-
nar (CyberKnife) setups were clearly superior to coplanar beam arrangements, especially
for rectum sparing. Patient-specific beam angle optimization may be time consuming,
and most TPSs do not have advanced algorithms for it. In this study, we used Erasmus-
iCycle to search for a fixed set of beam directions for all patients (i.e. a beam-angle class
solution [CS]), which could replace iBAS without loss in plan quality.
3.2 Methods and Materials
3.2.1 Patients
Computed tomography scans of 30 previously treated CyberKnife prostate SBRT pa-
tients with 1.5-mm slice thickness were used in this project. The planning target volume
(PTV) was defined as prostate plus 3-mm margin. The peripheral zone was contoured
using magnetic resonance images. Average PTV size was 95.6 ± 20.3 cm3 (range, 55.9-
147.2 cm3). Other contoured organs at risk (OARs) were rectum, bladder, urethra, femoral
heads, scrotum, and penis. A total dose of 38 Gy was delivered in 4 fractions with a
heterogeneous distribution mimicking high–dose rate brachytherapy dosimetry. In this
study an arbitrarily selected subgroup of 10 ”training” patients was used to create beam-
angle CSs. The same patients plus the remaining 20 ”test” patients were used for CS
validation.
3.2.2 Erasmus-iCycle plan generation
As described in detail below, Erasmus-iCycle was first used to automatically generate
15-, 20-, and 25-beam iBAS plans for a CyberKnife equipped with a multileaf collimator
(MLC). With these plans, 6 recipes for creation of beam-angle CSs were investigated. To
validate these CSs, Erasmus-iCycle was also used to generate IMRT plans using them
instead of iBAS.
Automated treatment planning with Erasmus-iCycle has been described in detail else-
where [22, 68, 135, 143, 184–186], and a brief summary is provided in the Introduction. The
wishlist used in this study, containing the hard constraints and planning objectives with
ascribed priorities for generation of clinically desired prostate SBRT dose distributions,
is presented in Tables 3.1 (constraints and objectives). Constraints (that will always be
respected in Erasmus-iCycle plans) are mainly used to control Dmax in the target and
OARs, the entrance dose, and the dose fall-o close to the PTV. Planning target volume
coverage and an inhomogeneous dose distribution mimicking high-dose rate brachy-
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therapy dosimetry are the objectives with the highest priorities (i.e. 1 and 2), optimized
through LTCP (logarithmic tumor control probability) functions, defined as follows:
LT CP =
1
m
m∑
j=1
e−α (dj−D
p ) (3.1)
where m is the number of voxels in the target structure, D p the prescribed dose, dj
the dose in voxel j , and α a parameter, called cell sensitivity (see reference [143] for
details). The OAR objective with the highest priority (3) is reduction of the rectum mean
dose as close as possible to 0 Gy.
We used the 102 beam directions of a CyberKnife M6 system as input for iBAS and
CS development. Currently only circular beam shapes, realized with fixed cones or a
variable aperture collimator, are available for clinical CyberKnife treatment. However,
an MLC is being developed by Accuray Inc, and in the near future the systems at our
facility will be equipped with one. The reported investigations have been performed
for a system with an MLC (characteristics provided by Accuray Inc and summarized in
reference [143]).
3.2.3 Workflow for generation of acceptable N-beam CSs
In a recent study [143] we demonstrated that average CyberKnife plan quality for our
clinical prostate SBRT dose prescription only began to level o after inclusion of at least
20 beams. Therefore, the initial investigations focused on creation of a 25-beam CS. For
a subgroup of 10 patients, Erasmus-iCycle was first used to generate 25- beam plans with
individualized beam angles. For each of the 6 investigated recipes for CS creation (de-
scribed below), the 25-beam CS was then generated and validated as follows: (1) Based
on the 10 generated iBAS plans, select 25 (fixed) beam directions according to the recipe;
(2) Use Erasmus-iCycle to generate IMRT plans with fixed beam directions determined in
step 1 for the chosen subset of 10 patients; and (3) Normalize for each patient the CS and
iBAS plans to have exactly equal V95% in the PTV dose-volume histograms, and compare
plan parameters.
This first step of the investigations allowed selection of a subset of recipes that re-
sulted in 25-beam CSs with clinically acceptable dierences in plan quality compared
with iBAS, as evaluated by the clinician participating in the study (S.A.).
With a CyberKnife treatment unit, treatment time generally increases with the number
of treatment beams, and not all patients benefit equally from 25 beams [143]. Therefore,
in a second step, we investigated whether the recipes also worked for generation of 20-
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Constraints
Volume Type Limit
PTV max 65 Gy
PZ max 69 Gy
Rectum max 38 Gy
Urethra max 40 Gy
Bladder max 41.8 Gy
Penis Scrotum max 4 Gy
Penis Scrotum mean 2 Gy
Ring 1* max 20 Gy
Ring 2† max 15 Gy
Objectives Parameters
Priority Volume Type Goal (Dp , α , sucient)
1 PTV ↓LTCP 0.03 (35 Gy, 0.7, 0.03)
2 PTV ↓LTCP 3.1(4.1‡) (58 Gy, 0.1, 3.1(4.1))
3 Rectum ↓mean 0 Gy
4 PZ ↓LTCP 1 (45.6 Gy, 0.9)
5 Urethra ↓mean 0 Gy
6 Bladder ↓mean 0 Gy
7 From Ring 1 to Ring 2 ↓max 15 Gy
8 Rectum ↓max 30 Gy
9 Bladder ↓max 35 Gy
10 Penis Scrotum ↓max 0
11 Left and right Femur head ↓max 24
Table 3.1: Wishlist applied for all iBAS and CS plan generations for all 30 study patients. Abbreviations: CS =
class solution; iBAS = individualized beam angle selection; PTV = planning target volume; PZ = peripheral
zone. LTCP = logarithmic tumor control probability.
*All tissues between 2 and 3 cm from the PTV. †All tissues between the body contour and the body
contour-2cm. ‡Depending on PTV homogeneity.
and 15-beam CSs. The latter was only performed for the subset of the 6 recipes, stated
below, that resulted in clinically acceptable 25-beam CSs, as selected in the previous
step. For these recipes, the 15- and 20-beam CSs were again created using the 10 training
patients (step 1 above). However, validation was now performed for all 30 patients (steps
2 and 3 above with 30 instead of 10 patients), with the 20 extra patients serving as an
independent test group, not involved in CS generation.
3.2.4 Investigated recipes for beam angle CS creation
The following 6 intuitively promising recipes for CS creation were investigated. For the
initial studies on 25-beam CSs (above), these recipes were evaluated in chronological
order, each one selected after a failure of the previous one in generating a CS that could
44
3
3.2
 Methods and Materials
replace iBAS without loss in plan quality. For all but 1 of these 6 recipes the beam selec-
tion criteria were based on plan parameters (eg beam weights) of Erasmus-iCycle iBAS
plans. For each recipe the methodology for choosing N (equal to 25, 20, or 15) directions
for a resulting N-beam CS is described.
• Recipe 1: Choose the N directions that were most frequently found in the iBAS
plans of the 10 training patients.
• Recipe 2: Choose N directions that ensure a uniform spread of beams over the
entire CyberKnife beam angle space.
• Recipe 3: Choose the N directions with the highest average contributions to PTV
D95% in the iBAS plans of the 10 training patients.
• Recipe 4: Choose the N directions with the highest average contributions to PTV
Dmean in the iBAS plans of the 10 training patients.
• Recipe 5: Choose the N directions with the highest average contributions to the
ratio PTV Dmean/rectum Dmean in the iBAS plans of the 10 training patients.
• Recipe 6: As in recipe 4, choice of directions was based on contribution to PTV
Dmean; however, after a priori removal of directions from the CyberKnife beam
angle space. In the initial iBAS plans for the 10 training patients, all directions
with a large lateral component had high average contributions to PTV Dmean. To
favor inclusion of also other directions in CS6, 25 of these lateral directions were
first removed from the full 102 direction CyberKnife beam set, and new iBAS-plans
were then generated for the 10 training patients using the remaining 77 available
angles as input. Recipe 4 was then applied again using the new iBAS-plans. In the
remainder of the article, CSi refers to a CS generated with recipe i.
3.2.5 Evaluation and comparison of iBAS and CS plans
Generated plans were evaluated by a physician (S.A.) to verify clinical acceptability.
Planning target volume dose delivery was evaluated by V95% and the near-minimum
dose, D98%. Organ at risk parameters compared in corresponding iBAS and CS plans
were rectum D1cc, V60GyEq, V40GyEq, and Dmean (in accordance with QUANTEC, Quan-
titative Analysis of Normal Tissue Eects in the Clinic [117]); urethra D1%, D10%, D50%;
and bladder D1cc and Dmean. As in our clinical practice, rectum sparing was consid-
ered most important in plan generation (see above) and plan comparison. Strong hard
constraints on femoral heads, penis, and scrotum (Table 3.1) guaranteed very low doses
in all plans, which are not reported in the Results. All CS-iBAS plan comparisons were
done after normalizing the higher PTV V95% plan to the lower, to make a comparison
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based on OAR sparing with equal PTV coverage, without violating the constraints. Two-
sided Wilcoxon signed-rank tests were used to compare plan parameters in iBAS and CS
plans. Dierences with a P value <.05 were considered statistically significant. To de-
cide on acceptability of a CS, dierences with iBAS in mean plan parameter values were
considered relevant if both clinically and statistically significant.
3.2.6 Robustness of the final 25-beam CS for changes in PTV margin and
PTV dose inhomogeneity
The final 25-beam CS was developed to generate plans for our clinical conditions (e.g.
a 3-mm PTV margin and a desired highly inhomogeneous PTV dose distribution). In case
of patient treatment without CyberKnife intrafraction prostate tracking, we would use a
PTV margin of 5 mm. Other groups apply less inhomogeneous PTV doses as compared
with our institution. Therefore, in a separate study we investigated whether the 25-beam
CS developed for our clinical situation could still replace iBAS in case of a PTV margin
of 5 mm, or a change in the goal value of the second LTCP cost function in the wishlist
from 3.1 to 4.1 to generate plans with reduced PTV dose inhomogeneity.
3.3 Results
The upper 3 rows of Table 3.2 show PTV plan parameters for 15-, 20-, and 25-beam
iBAS plans, and dierences with CS plans generated with recipe 6. As mentioned above,
compared iBAS and CS plans were first normalized to have equal PTV V95%. Clearly, near-
minimum PTV doses and dose homogeneities also were very similar. Therefore, in the
remainder of this article only OAR doses are reported. As visible in Figure 3.1a, CyberKnife
M6 node positions are not symmetrically distributed around the patient, especially in
the inferior-superior direction. Therefore, in an introductory study we established the
preferable patient setup on the treatment couch, to be used in CS and iBAS plan com-
parisons.
To this purpose, 25-beam iBAS plans, generated with the patient’s head directed to-
ward the CyberKnife robot, were compared with plans with the feet pointing toward the
robot. This study showed consistently better rectum sparing for the latter plans (on aver-
age 2.1 Gy, 0.4%, -1.3%, and 1.0 Gy for D1cc, V60GyEq, V40GyEq, and Dmean, respectively),
although bladder D1cc and Dmean were on average increased by 3.8 Gy and 1.0 Gy, re-
spectively (Fig. 3.A1; available at the end of the chapter or online at www.redjournal.org).
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Figure 3.1: (a) The full CyberKnife beam angle space (102 directions, indicated by dots and circles), and the 25
directions in the 25-beam class solution (CS)6 (grey crosses). (b-e) For 4 training patients, beam directions
selected with individualized beam angle selection (iBAS) in 25-beam plans (circles) and the 25 CS6 directions
(grey crosses). The dots in (a) represent beam directions that were not selected during 25-beam iBAS for any
of the 10 training patients. In all graphs, the size of the circles is proportional to the contribution to planning
target volume Dmean in iBAS plans; that is, in (a) mean contributions for the 10 training patients are
depicted. The couch is schematically represented, and nodes are indicated by their gantry (x) and couch (y)
angles.
47
3
3
 Beam angle class solutions for prostate SBRT
25
Be
am
CS
*
20
Be
am
CS
15
Be
am
CS
iB
AS
CS
-i
BA
S
iB
AS
CS
-i
BA
S
iB
AS
CS
-i
BA
S
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
PT
V V 9
5%
(%
)
98
.4
[9
7.2
,9
9.
4]
-0
.1
±0
.2
.0
05
98
.5
[9
7.5
,9
9.
6]
-0
.4
±0
.3
<
.0
01
98
.9
[9
7.7
,10
0.
0]
-0
.3
±0
.3
<
.0
01
D 9
8%
(G
y)
36
.6
[3
5.
0,
38
.0
]
-0
.2
±0
.3
.0
07
36
.8
[3
5.
4,
38
.3]
-0
.5
±0
.3
<
.0
01
37
.1
[3
5.7
,38
.8
]
-0
.4
±0
.4
<
.0
01
D 5
%
/D
95
%
()
1.
5
[1.
5,1
.6
]
0.
0
±0
.0
.16
4
1.
5
[1.
5,1
.6
]
0.
0
±0
.0
.0
02
1.
5
[1.
4,1
.6
]
0.
0
±0
.0
.0
23
Re
ct
um
D 1
c
c
(G
y)
29
.2
[2
2.
2,
34
.4
]
0.
1
±0
.5
.33
9
30
.1
[2
4.
2,
35
.6
]
-0
.7
±0
.6
<
.0
01
32
.0
[2
6.
6,
36
.8
]
-0
.5
±0
.8
.0
02
V 6
0G
y
E
q
(%
)
1.
6
[0
.1,
3.5
]
0.
1
±0
.2
.2
89
2.
0
[0
.2
,5
.5
]
-0
.2
±0
.3
<
.0
01
3.
2
[0
.6
,10
.8
]
-0
.4
±0
.5
<
.0
01
V 4
0G
y
E
q
(%
)
4.
4
[1.
0,
8.
7]
0.
2
±0
.3
.0
06
5.
2
[1.
6,1
2.
4]
-0
.3
±0
.3
<
.0
01
7.7
[2
.4
,2
2.
2]
-0
.5
±0
.9
.0
03
D m
e
a
n
(G
y)
4.
9
[3
.0
,7.
7]
0.
1
±0
.2
<
.0
01
5.
4
[3
.2
,9.
3]
-0
.1
±0
.2
<
.0
01
6.
8
[3
.9,
13
.5
]
-0
.3
±0
.5
.0
02
Ur
et
hr
a
D 1
%
(G
y)
40
.5
[3
9.7
,4
2.1
]
-0
.1
±0
.4
.13
3
40
.5
[3
9.
8,
41
.9
]
-0
.4
±0
.5
<
.0
01
40
.6
[3
9.9
,41
.5
]
-0
.5
±0
.5
<
.0
01
D 1
0%
(G
y)
39
.6
[3
8.
8,
40
.9
]
-0
.1
±0
.5
.5
37
39
.7
[3
8.
6,
41
.2
]
-0
.4
±0
.5
<
.0
01
39
.8
[3
9.
0,
40
.7]
-0
.4
±0
.4
<
.0
01
D 5
0%
(G
y)
37
.9
[3
6.
6,
39
.4
]
-0
.0
±0
.4
.91
8
38
.1
[3
6.
7,3
9.
4]
-0
.3
±0
.4
.0
01
38
.3
[3
6.
5,
39
.5
]
-0
.3
±0
.4
<
.0
01
Bl
ad
de
r
D 1
c
c
(G
y)
42
.2
[3
6.
0,
45
.2
]
0.
5
±0
.4
<
.0
01
42
.1
[3
5.
3,
44
.9
]
0.
7
±0
.6
<
.0
01
42
.3
[3
6.
0,
44
.5
]
0.
5
±0
.6
<
.0
01
D m
e
a
n
(G
y)
10
.6
[4
.3,
15
.8
]
1.1
±0
.7
<
.0
01
11
.5
[5
.0
,16
.9
]
1.1
±0
.9
<
.0
01
13
.1
[6
.6
,18
.9
]
0.
9
±1
.1
<
.0
01
Ta
bl
e
3.
2:
Fo
r1
5,
20
,a
nd
25
be
am
s,
co
m
pa
ris
on
s
of
iB
AS
an
d
CS
6
pl
an
s
in
cl
ud
in
g
al
l3
0
pa
tie
nt
s.
Ab
so
lu
te
va
lu
es
fo
ri
BA
S
pl
an
s
ar
e
pr
es
en
te
d
an
d
ab
so
lu
te
di
e
re
nc
es
be
tw
ee
n
CS
6
an
d
iB
AS
.*
Di
e
re
nc
e
st
at
is
tic
al
ly
si
gn
ifi
ca
nt
,b
ut
sm
al
le
rt
ha
n
.0
5.
48
3
3.3
 Results
25
Be
am
s
CS
*
3m
m
PT
V
m
ar
gi
n,
No
rm
al
In
ho
m
og
.
5m
m
PT
V
m
ar
gi
n,
No
rm
al
In
ho
m
og
.
3m
m
PT
V
m
ar
gi
n,
Lo
w
er
In
ho
m
og
.
iB
AS
**
CS
-i
BA
S
iB
AS
CS
-i
BA
S
iB
AS
CS
-i
BA
S
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
M
ea
n
[R
an
ge
]
M
ea
n
±S
D
p
PT
V V 9
5%
(%
)
98
.2
[9
7.0
,9
9.
5]
0.
0
±0
.0
1.0
00
98
.4
[9
7.5
,9
8.
9]
0.
0
±0
.0
1.0
00
98
.2
[9
7.2
,9
9.
4]
0.
0
±0
.0
1.0
00
D 9
8%
(G
y)
36
.3
[3
4.9
,37
.8
]
0.
0
±0
.1
.14
0
36
.5
[3
5.
4,
37
.1]
0.
0
±0
.1
.46
0
36
.4
[3
5.
0,
38
.0
]
0.
0
±0
.1
.43
0
D 5
%
/D
95
%
()
1.
4
[1.
3,1
.5
]
0.
0
±0
.0
.9
90
1.
5
[1.
5,1
.6
]
0.
0
±0
.0
.0
30
1.
6
[1.
5,1
.6
]
0.
0
±0
.0
.2
00
Re
ct
um
D 1
c
c
(G
y)
29
.0
[2
1.8
,33
.7]
0.
1
±0
.4
.0
50
34
.1
[2
6.1
,37
.1]
-0
.3
±0
.7
.0
50
29
.0
[2
1.9
,34
.4
]
0.
2
±0
.4
.0
10
V 6
0G
y
E
q
(%
)
1.
5
[0
.1,
3.3
]
0.
1
±0
.1
.0
10
4.
2
[0
.6
,8
.4
]
-0
.2
±0
.4
<
.0
01
1.
5
[0
.1,
3.
4]
0.
1
±0
.2
<
.0
01
V 4
0G
y
E
q
(%
)
4.
1
[0
.9,
8.
2]
0.
2
±0
.2
<
.0
01
8.
0
[2
.2
,15
.1]
-0
.6
±0
.7
<
.0
01
4.
3
[1.
0,
8.
7]
0.
2
±0
.3
<
.0
01
D m
e
a
n
(G
y)
4.
6
[2
.8
,7.
0]
0.
1
±0
.1
<
.0
01
6.
4
[3
.7,
10
.0
]
-0
.7
±0
.7
<
.0
01
4.
9
[3
.0
,7.
7]
0.
1
±0
.2
<
.0
01
Ur
et
hr
a
D 1
%
(G
y)
40
.0
[3
9.
0,
40
.9
]
0.
1
±0
.5
.17
0
40
.4
[3
8.
7,4
1.6
]
-0
.5
±0
.7
<
.0
01
40
.2
[3
9.
0,
41
.8
]
0.
1
±0
.5
.5
20
D 1
0%
(G
y)
39
.2
[3
8.
0,
40
.1]
0.
1
±0
.4
.11
0
39
.5
[3
7.9
,4
0.
6]
-0
.4
±0
.6
<
.0
01
39
.3
[3
8.
4,
40
.6
]
0.
1
±0
.5
.27
0
D 5
0%
(G
y)
37
.7
[3
6.
3,3
9.
0]
0.
2
±0
.4
.0
40
38
.0
[3
6.
6,
39
.3]
-0
.3
±0
.6
.0
10
37
.7
[3
6.
3,3
9.
2]
0.
2
±0
.5
.0
40
Bl
ad
de
r
D 1
c
c
(G
y)
40
.5
[3
3.8
,4
4.
0]
0.
6
±0
.5
<
.0
01
43
.0
[3
8.
4,
44
.8
]
-1
.2
±1
.6
<
.0
01
41
.9
[3
5.7
,4
5.
2]
0.
7
±0
.6
<
.0
01
D m
e
a
n
(G
y)
9.
3
[2
.9,
14
.7]
1.1
±0
.6
<
.0
01
12
.8
[5
.2
,2
0.
4]
-1
.4
±2
.0
<
.0
01
10
.6
[4
.3,
15
.8
]
1.1
±0
.7
<
.0
01
Ta
bl
e
3.3
:F
or
al
l3
0
pa
tie
nt
s,
co
m
pa
ris
on
of
25
-b
ea
m
iB
AS
an
d
CS
6
pl
an
s
fo
r:
(1)
th
e
cl
in
ic
al
PT
V
m
ar
gi
n
an
d
do
se
ho
m
og
en
ei
ty
(le
ft
co
lu
m
ns
);
(2
)a
n
in
cr
ea
se
d
PT
V
m
ar
gi
n
(m
id
dl
e
co
lu
m
ns
);
an
d
(3
)a
re
du
ce
d
PT
V
do
se
in
ho
m
og
en
ei
ty
(ri
gh
tc
ol
um
ns
).C
S6
wa
s
de
riv
ed
us
in
g
th
e
cl
in
ic
al
se
tti
ng
s.
Ab
so
lu
te
va
lu
es
fo
ri
BA
S
pl
an
s
ar
e
pr
es
en
te
d
an
d
ab
so
lu
te
di
e
re
nc
es
be
tw
ee
n
CS
6
an
d
iB
AS
.*
CS
=
Cl
as
s
So
lu
tio
n.
**
iB
AS
=
in
di
vi
du
al
ize
d
Be
am
An
gl
e
Se
le
ct
io
n.
49
3
3
 Beam angle class solutions for prostate SBRT
In the remainder of the study, plans were generated for a patient set up with the
feet in the direction of the robot. Figure 3.1b-e shows examples of individualized beam
angle selection. Although there are clear dierences between the 4 presented patients
in selected orientations, all patients show a strong preference for beam angles with a
large lateral component (compare with Fig. 3.1a).
3.3.1 Selection of the final recipe for generation of acceptable CSs
For each of the investigated CS recipes, Figure 2 shows the dierences in rectum para-
meters between 25-beam CS and iBAS plans for the 10 training patients. Clearly, CS6 re-
sulted in rectum doses that were very similar to those obtained with iBAS. With recipes 2,
3, and 5, for each patient, all rectum plan parameters were deteriorated in the CS plans.
Recipes 1 and 4 resulted in CSs with some deterioration in rectum doses, which were
smallest with the former. These observations led to the decision to consider recipes
1 and 6 for further validation and use them to generate also CSs for 15- and 20-beam
plans, to be compared with iBAS plans with equal numbers of beams.
Figure 3.3 shows for recipes 1 and 6 dierences in rectum dose delivery for all 30 pa-
tients for 15, 20, and 25 beams, clearly demonstrating that only recipe 6 resulted in ac-
ceptable CS rectum dose delivery for all beam numbers. Table 3.2 confirms the accept-
ability of rectum doses in the CS6 plans. Furthermore, it shows that also urethra and
bladder dose parameters in the CS6 plans were very close to those in the iBAS plans.
Therefore, recipe 6 is the preferred recipe for CS generation. Figure 3.1a shows graph-
ically which beam directions were selected in the 25-beam CS6 (grey crosses). Figure
3.1b-e compares the 25-beam CS6 (grey crosses) with the 25 beams selected in the iBAS
plans for 4 randomly selected training patients.
3.3.2 Robustness of the final 25-beam CS for changes in PTV margin and
required PTV dose inhomogeneity
The 25-beam CS6 was created using plans with a (clinical) PTV margin of 3 mm and a
clinically realized D5%/D95% of 1.54 ± 0.03. Table 3.3 shows that using CS6 to generate
plans for a PTV margin of 5 mm or a D5%/D95% of 1.42 ± 0.00 resulted in very similar
OAR dose parameters as in corresponding iBAS plans, for all 30 patients.
3.3.3 Optimization time reduction
Using CS6 instead of iBAS in treatment planning (i.e. avoiding computationally expen-
sive individualized beam angle selection) resulted in a reduction in optimization time
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Figure 3.2: For all 6 investigated class solution (CS) recipes, comparison of rectum plan parameters for
25-beam individualized beam angle selection (iBAS) plans with corresponding 25-beam CS plans generated
for the 10 training patients. Positive dierences point at higher rectum doses for CS plans.
by a factor 14 to 25 without loss in plan quality. Optimization times of 4 and 13 hours
for 15- and 25-beam iBAS plans decreased to 17 and 31 minutes for 15- and 25-beam CS6
plans. The calculations were performed on a dual Intel Xeon E5-2690. The code was
multi-threaded and used all 16 central processing unit cores.
3.4 Discussion
In this study we investigated 6 recipes for generation of beam angle CSs for robotic
prostate SBRT, to be used instead of beam angle optimization for each individual patient.
A CS was considered acceptable if it resulted in clinically insignificant deteriorations in
plan quality compared with iBAS. The idea of this project came from an observation in
our previous work [143] of high frequency of selection of beams from the 2 lateral areas
in iBAS plans for all patients.
Although all investigated recipes were intuitively considered promising, in the end
only 1 resulted in acceptable CSs for 15-, 20-, and 25-beam plans. The initial studies
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using only the 10 training patients and 25-beam plans were performed in chronologi-
cal order, starting with recipe 1 and ending with recipe 6. Every time, a new recipe was
introduced because the previous one was not found convincing owing to plan quality
loss compared with iBAS. The first 4 recipes were rather straightforward, but these sim-
ple recipes did not result in acceptable CSs. Additionally, recipe 5 was not successful,
considering both PTV Dmean and rectum Dmean together, but performing even worse
than some of the simpler ones. The finally selected recipe 6 is a refinement of recipe 4.
Because of the abundance of lateral beams with high PTV Dmean contributions in the
25-beam iBAS plans (Fig. 3.1a), the latter recipe resulted in a 25-beam CS with almost
exclusively directions belonging to the 2 lateral areas. With the high focus on the lat-
eral areas and the resulting lack of other directions, recipe 4 did not perform well. It
was hypothesized that if some of the beams within these highly populated lateral ar-
eas (in practice 25) were removed from the input set for iBAS, equal quality iBAS plans
would be generated with missing directions being substituted by remaining neighboring
directions. This was indeed confirmed, and plans with no significant quality loss com-
pared with the original iBAS plans, generated with the full CyberKnife beam angle search
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space, were created. Applying then again recipe 4 (ie direction selection based on high
PTV Dmean weights), the successful CS6 could be created, including also beams outside
the lateral areas.
As shown in Figure 3.3 and Table 3.2, for 15-beam and 20- beam plans, CS6 performed
on average even slightly better than iBAS. We do not have a definitive explanation for
this. Beam angle selection is a discrete, non-convex, combinatorial problem with pos-
sibilities of finding (slightly) suboptimal solutions. Possibly, for the smaller beam num-
bers, some uncertainty or randomness inherent in the process used by iBAS to find the
highest-quality solutions can be avoided by using CS6, which assures the use of fixed
directions that, according to recipe 6, performed best on average for the population.
For this project, a large number of plans was generated: 70 plans for the pre-selection
of the 2 most promising recipes, 240 more plans to select the final recipe and validate it,
and another 120 plans to verify robustness of the final 25-beam CS for a change in PTV
margin or prescribed PTV dose inhomogeneity. Additional plans were generated for the
a a priori establishment of the wishlist for generation of high quality, clinically desirable
plans. Clearly, without automated treatment planning as provided by Erasmus-iCycle, it
would not have been possible to generate all these plans. Moreover, because of the
automation using a unique wishlist, plan quality was not operator dependent, avoiding
undesirable variations in quality (”noise”) and potential bias in the comparison of iBAS
and CS plans. Another strong point of this study is that for the final recipe choice, CS
and iBAS plan comparisons were not only performed for the 10 training patients used
to generate the CSs but also for 20 independent patients, not considered during CS cre-
ation. What is clear is that we could identify a recipe that worked for generation of
high-quality 15- to 25-beam beam-angle CSs. The 25-beam CS was also proven to be
robust for changes in PTV margin and prescribed PTV dose inhomogeneity (not investi-
gated for the 15- and 20-beam CSs). Only a few articles about coplanar CS generation
are available in the literature [97, 123, 191]. This study cannot guarantee that alternative
CSs do not exist that perform even better on average, nor can it guarantee that a sim-
pler or less computationally expensive recipe cannot be generated. Clinical plans for
the CyberKnife are generated with the Multiplan TPS, also provided by Accuray Inc. One
of our future research topics is a study on the impact of the selected CS on plan quality
and treatment planning time with Multiplan. We will also investigate whether the same
recipe would work for other treatment sites.
3.5 Conclusions
Using an in-house TPS for automated IMRT treatment plan generation and individual-
ized beam angle selection, we developed a recipe for generation of beam angle CSs for
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robotic prostate SBRT, to be used instead of time-consuming beam angle optimization
for each individual patient. Using the developed recipe, 15-, 20-, and 25-beam CSs could
be established without loss in plan quality compared with patient-specific beam angle
selection. With the CS, 25-beam plans could be generated in 31 minutes, compared with
13 hours for iBAS. Establishing a recipe for creation of high-quality beam angle CSs can
be a non trivial task, because intuitively promising candidate recipes can severely fail.
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Supplementary Figure 1: For all 10 training patients, comparison of rectum, urethra and bladder parameters for 
25−beam iBAS plans with head first position (HFP), i.e. with head poiting towards the robot, and feet first 
position (FFP) patient setup. Positive differences point at higher OAR doses for HFP plans.Figure 3.A1: Supplementary Figure. For all 10 training patients, comparison of rectum, urethra and bladder
parameters for 25-beam iBAS plans with head first position (HFP), i.e. with head pointing towards the robot,
and feet first position (FFP) patient setup. Positive dierences point at higher OAR doses for HFP plans.
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Abstract
Background: For conventional radiotherapy treatment units, automated planning can
significantly improve plan quality. For robotic radiosurgery, systems for automatic gen-
eration of clinically deliverable plans do not yet exist. For prostate stereotactic body
radiation therapy (SBRT), few studies have systematically compared VMAT with robotic
treatment.
Material and Methods: The multi-criteria autoplanning optimizer, developed at our in-
stitute, was coupled to the commercial treatment planning system of our robotic treat-
ment unit, for fully automated generation of clinically deliverable plans (autoROBOT).
The system was then validated by comparing autoROBOT plans with manually gener-
ated plans. Next, the autoROBOT system was used for systematic comparisons between
autoROBOT plans and VMAT plans, that were also automatically generated (autoVMAT).
CTV–PTV margins of 3 mm were used for autoROBOT (clinical routine) and autoVMAT plan
generation. For autoVMAT, an extra plan was generated with 5 mm margin (often applied
for VMAT). Plans were generated for a 4x9.5 Gy fractionation scheme.
Results: Compared to manual planning, autoROBOT improved rectum D1cm3 (16%),
V60GyEq (75%) and Dmean (41%), and bladder Dmean (37%) (all p≤0.002), with equal PTV
coverage. In the autoROBOT and autoVMAT comparison, both with 3 mm margin, rec-
tum doses were lower for autoROBOT by 5% for rectum D1cm3 (p=0.002), 33% for V60GyEq
(p=0.001), and 4% for Dmean (p=0.05), with comparable PTV coverage and other OAR spa-
ring. With 5 mm margin for VMAT, 18/20 plans had a PTV coverage lower than requested
(<95%) and all plans had higher rectum doses than autoROBOT (mean percentage dif-
ferences of 13% for D1cm3 , 69% for V60GyEq, and 32% for Dmean (all p<0.001)).
Conclusion: The first system for fully automated generation of clinically deliverable
robotic plans was built. Autoplanning did largely enhance robotic plan quality, com-
pared to manual planning. Using autoplanning for both the robotic system and VMAT,
superiority of non–coplanar robotic treatment compared to coplanar VMAT for prostate
SBRT was demonstrated.
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4.1
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4.1 Introduction
In prostate stereotactic body radiation therapy (SBRT), patients are treated with large
fraction doses, requiring high accuracy delivery and with image–guided dose delivery
[6, 18, 24, 55, 57, 74, 81, 89, 108, 176]. Both C–arm linacs [43, 82, 94, 194] and robotic units
[6, 55, 57, 81, 89, 176]. have been used for prostate SBRT.
Recent findings on the potential added value of non–coplanar setups for prostate SBRT
instead of coplanar treatment are contradictory [43, 102, 107, 143]. Two recent studies
have compared robotic treatment and VMAT for prostate SBRT [102, 107]. MacDougall et
al. [107] found no discernible dosimetric dierences, based on only 6 patients. Lin et
al. [102] concluded that VMAT was preferable because of reduced treatment time and
superior dose distribution conformality. In both studies, all plans were generated man-
ually, and clinically delivered plans were retrospectively compared with an alternative
plan. Both the manual planning and retrospective comparisons may have introduced
bias and noise in the technique comparisons.
Recently, several systems have been proposed for planning automation [22, 93, 137,
138, 169, 185, 197, 199, 201], all for treatment with C–arm linacs. In this work, we have de-
veloped the first system for automatic generation of deliverable plans for non–coplanar
robotic treatment (autoROBOT). Basis of the autoROBOT planning system is a multi-
criterial optimizer that was also the core of a recently developed system for automatic
VMAT plan generation for C–arm linacs [156, 185]. The developed autoROBOT planning
system was first evaluated by comparing manually generated prostate SBRT plans with
autoROBOT plans. We then used the autoROBOT and autoVMAT planning systems to sys-
tematically compare robotic and VMAT treatment for prostate SBRT. The use of exactly
the same plan optimization scheme for autoROBOT and autoVMAT (described below) al-
lowed bias–free technique comparisons and allowed generation of new input for the
on–going debate [43, 102, 107, 143] on potential added value of non–coplanar prostate
SBRT, compared to coplanar treatment.
4.2 Materials and Methods
4.2.1 Patients
In this study, contoured CT scans of 20 prostate SBRT patients, previously treated with
the robotic M6 CyberKnife (Accuray Inc, Sunnyvale, USA), were used. A planning target
volume (PTV) with a 3 mm isotropic margin around the prostate (PTV3mm) was used for
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clinical planning [176]. In the investigations, both autoROBOT and autoVMAT plans were
generated for PTV3mm. AutoVMAT plans were also generated for PTV5mm, as often applied
for C–arm linac prostate SBRT. Average PTV3mm and PTV5mm sizes were 91.2 cm3 [57.8-142.3
cm3] and 109.5 cm3 [71.1-165.7 cm3], respectively.
Contoured OARs were rectum (outer contour), rectal mucosa (3 mm wall), bladder, ure-
thra, femoral heads, scrotum and penis. All plans simulated delivery of 38 Gy in 4 frac-
tions, with highly heterogeneous dose distributions to emulate high dose–rate brachy-
therapy dosimetry [143].
Five patients were used for configuration of the autoROBOT and autoVMAT planning
systems (below). The automated workflows were then applied to all 20 patients. For
validation of the autoROBOT planning system, autoROBOT plans for the first 10 study pa-
tients were compared to the manually generated and clinically delivered plans. For all 20
patients, autoROBOT plans were compared with autoVMAT3mm plans and autoVMAT5mm
plans.
4.2.2 Automated plan generation
4.2.2.1 The autoVMAT and autoROBOT planning systems
Basis of autoROBOT and autoVMAT plan generation was the Erasmus–iCycle multi–
criterial optimizer for generating Pareto–optimal and clinically favorable plans [22]. For
practical and legal reasons, Erasmus–iCycle plans cannot be directly used clinically.
However, we have recently coupled Erasmus–iCycle to the Monaco treatment planning
system (TPS) (Elekta AB, Stockholm, Sweden) for fully automated, multi–criterial genera-
tion of IMRT and VMAT plans for clinical delivery at a linac; based on the Erasmus–iCycle
dose distribution, a patient–specific Monaco template is automatically produced, to be
used for automated final plan generation. Eectively, Erasmus–iCycle first optimizes the
plan, while Monaco converts it into a clinically deliverable plan, see [185] for details. The
resulting plan quality is equal, or superior to the quality of manually generated plans,
and the system is now in routine clinical use [38, 67, 155, 185, 186].
For this study, we have configured (see below) the system for generating dual, full–
arc autoVMAT plans for prostate SBRT according to our clinical protocol, deliverable at
an Elekta linac equipped with an Agility MLC. Final plans were generated with Monaco
version 5.10 (Elekta AB, Stockholm, Sweden).
For automated multi–criterial generation of autoROBOT plans, a special version of
Erasmus–iCycle was prepared for plan optimization for the IRIS variable aperture colli-
mator (Accuray AB, Sunnyvale, USA), mounted on the CyberKnife. Basis was a previously
60
4
4.2
 Materials and Methods
developed version for optimization with fixed cone diameters and non–coplanar beam
set–ups [189]. This system was modified to handle the available non–coplanar beam
directions (nodes) of our novel M6 CyberKnife systems and the IRIS collimator, i.e. 117
node positions from the full body path. For fully automated generation of final, deliver-
able plans, this Erasmus–iCycle version was coupled to the Multiplan TPS (version 5.1.3)
that comes with the CyberKnife, similar to the system built for linacs (above). Similar to
the linac solution, automatically produced individualized planning templates were used
as intermediate between Erasmus–iCycle and Multiplan, aiming at generating clinically
deliverable plans that dosimetrically mimicked the initial Erasmus–iCycle plans. As in
clinical practice, the goal was to keep the delivery time below 45 min. Apertures from 10
to 40 mm diameter could be selected, as used clinically for manually generated plans.
4.2.2.2 Configuration of autoVMAT and autoROBOT planning
As described above, both for autoVMAT and autoROBOT planning, Erasmus–iCycle is
used for plan optimization, while the respective clinical planning systems are used for
mimicking the Erasmus–iCycle plan. Plan generation with Erasmus–iCycle is based on a
’wish–list’, containing the hard planning constraints and planning objectives with their
goal values and assigned priorities [22]. For each treatment site/treatment technique, a
dedicated wish–list is configured, which is then used for automated plan generation for
all involved patients, without further change.
In this study a single wish–list was generated and applied both for autoVMAT and
autoROBOT planning.
Using the same wish–list for both techniques is a key aspect of this study, since it al-
lowed to perform a fair like for like comparison of the two delivery techniques. Technical
details on the developed wish–list for prostate SBRT are presented in supplementary
material.
4.2.3 Plan evaluation and comparison
In this study, plan comparisons were mainly focused on our clinical aims. For the PTV,
the near–minimum dose (D98%) and the coverage (V100%) were evaluated. A coverage
of 95% is requested for clinical plans (V100%=95%), while a coverage between 93% and
95% is still acceptable if necessary to fulfil OAR constraints. Rectum is considered the
most important OAR, focusing at the high doses with D1cm3 <32.3 Gy. For bladder, the
D1cm3 requirement is <38 Gy. Urethra D50% and D5% constraint values are 40 and 45.5 Gy,
respectively.
Apart from these clinically used plan parameters, we also evaluated and compared
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Dmean for both rectum and bladder, V40Gy and V60Gy (2 Gy/fx equivalent dose) for rectum,
as suggested by QUANTEC [117], as well as the dose bath, looking at patient volumes
receiving >30, >20, >10, >5 and >3 Gy, as 5% of maximum dose.
When PTV coverage was achieved (>95%) for both plans, the plan with the slightly
higher coverage was re–normalized to the value of the other plan. This approach mini-
mized bias in comparison of OAR doses, related to dierent PTV coverages. Two–sided
Wilcoxon signed–rank tests were performed to compare plan parameters, using p<.05
as cut–o for statistical significance.
Apart from plan quality comparisons based on DVH metrics, for each patient, au-
toROBOT and autoVMAT plans were also compared by the participating clinician (S.A),
who scored quality dierences using Visual Analogue Scales (VAS) as presented in the
Results section. PTV, rectum, bladder, urethra, and overall quality were scored sepa-
rately. In total 40 of these plan comparisons (20 patients; autoROBOT vs. autoVMAT3mm
and autoROBOT vs. autoVMAT5mm) were performed in a random order. In each compari-
son, the two plans were presented side–by–side to the clinician, who did not know which
plan was presented on the left and which on the right of the screen (also here random
ordering).
To investigate clinical deliverability of automatically generated plans, dosimetric Qua-
lity Assurance (QA) was performed , as done in our clinical routine. To this purpose, for
5 arbitrarily selected patients, independent dose calculations were performed for the
autoROBOT plans, and measurements for autoVMAT plans with 3 and 5 mm margin. For
the autoROBOT plans, beam directions and weights were used to recalculate the entire
3D dose distribution with the Monte–Carlo dose computation software SciMoCa (Scien-
tific RT, Munich). For autoVMAT, plans were delivered while irradiating a 2D–array in an
Octavius phantom (PTW, Freiburg). 3D (autoROBOT) and 2D (autoVMAT) gamma analy-
ses were performed with 5% cut-o, 3% global maximum dose and 1 mm distance to
agreement (3%/1mm) criteria, and 95% passing rate threshold.
4.3 Results
4.3.1 autoROBOT vs. manual robotic planning
All manually and automatically generated plans for robotic treatment fulfilled clinical
requirements.
Automated planning improved plan quality compared to the manually generated plans
used for patient treatments, as visible in population average DVHs in figure 4.1. Dier-
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ences in PTV coverage were negligible (95.0% and 95.2% for manual and autoROBOT
plans (p=0.9)), but large dierences in OAR doses were observed; each patient plan im-
proved with automated planning compared to manual planning. On average, rectum
D1cm3 was reduced from 31.2 to 26.3 Gy (16% reduction, p=0.002), V60Gy from 2.4 to 0.6%
(75% reduction, p=0.002) and rectum Dmean from 10.4 to 6.1 Gy (41% reduction, p=0.002).
Bladder Dmean was improved from 14.0 (manual planning) to 6.1 Gy with automated plan-
ning (36% reduction, p=0.002).
Figure 4.1: Population average DVHs for automatically generated robotic plans (autoROBOT, solid lines) and
manually generated robotic plans (Manual, dashed lines), the latter used for patient treatment.
4.3.2 autoROBOT vs. autoVMAT plan quality
4.3.2.1 autoROBOT vs. autoVMAT3mm
Both the autoROBOT and autoVMAT3mm plans with V100% >95% could be generated for
all patients, as visible in table 4.1. The near–minimum PTV dose was on average slightly
higher for autoROBOT plans and the CI was lower (Table 4.1, Fig. 4.3A).
For the rectum (highest priority OAR), all parameters were on average lower for the au-
toROBOT with reduction of 5% for D1cm3 , 32% for V60GyEq, 22% for V40GyEq and 4% for Dmean,
(Table 4.1, Fig. 4.3B). Superiority in rectum dose parameters was observed in 15-17 of the
20 study patients (Table 4.1), where dierences were considered to have real clinical im-
pact for 8 patients (see clinical scoring below). For the 3-5 patients with a rectum dose
advantage for autoVMAT3mm, the dierences with the robotic system were always small
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autoROBOT autoVMAT3mm autoVMAT5mm
VMAT - ROBOT [%]∗ VMAT - ROBOT [%]
Mean [Range] Mean Mean [Range] p #Pts∗∗ Mean Mean [Range] p #Pts
PTV
V100% [%] 95.2 [95.0,95.5] 95.3 0 [-1,0] .3 8 92.7 3 [0,7] <.001 20
D98% [Gy] 36.1 [35.2,36.9] 35.8 1 [-2,3] .01 13 33.7 7 [3,13] <.001 20
CI∗∗∗ 1.1 [1.1,1.1] 1.2 6 [3,10] <.001 20 1.2 6 [2,10] <.001 20
Rectum
D1cm3 [Gy] 28.0 [23.0,33.5] 29.4 5 [-3,18] .002 16 32.2 13 [1,23] <.001 20
V60GyEq [%] 1.1 [0.3, 2.6] 1.5 32 [-26,77] .001 17 3.3 69 [15,89] <.001 20
V40GyEq [%] 3.8 [1.9, 6.0] 4.9 22 [-13,56] <.001 17 9.2 58 [24,76] <.001 20
Dmean [Gy] 6.3 [4.2, 7.7] 6.6 4 [-18,25] .05 15 9.3 32 [14,45] <.001 20
Bladder
D1cm3 [Gy] 37.4 [36.4,39.1] 37.2 -1 [-6,2] .3 9 37.6 0 [-3,3] .4 12
Dmean [Gy] 9.7 [6.5,13.0] 8.4 -18 [-45,7] <.001 2 9.3 -6 [-32,15] .1 7
Urethra
D5% [Gy] 40.4 [39.4,42.3] 40.9 1 [-4,6] .06 13 41.6 3 [-3,8] .001 17
D50% [Gy] 38.3 [37.5,39.2] 38.5 1 [-3,3] .2 14 39.1 2 [-1,6] <.001 17
Patient
V3Gy [cc] 4910 [3428,7064] 4378 -12 [-30,11] .001 4 4669 -5 [-22,16] .05 6
V5Gy [cc] 3143 [2147,4779] 3538 12 [-5,28] <.001 18 3864 19 [3,35] <.001 20
V10Gy [cc] 1137 [737,1872] 1583 29 [19,37] <.001 20 1789 37 [24,47] <.001 20
V20Gy [cc] 293 [203,442] 342 14 [5,20] <.001 20 392 25 [17,34] <.001 20
V30Gy [cc] 150 [103,229] 159 5 [0, 9] <.001 20 182 18 [12,24] <.001 20
Table 4.1: For all 20 patients, comparisons of autoROBOT with autoVMAT3mm and autoVMAT5mm plans.
∗Percentage dierences are expressed as ±|100 ∗ (autoVMAT − autoROBOT)/autoVMAT | with positive
dierences representing better performance for robotic.
∗∗Number of patients with superior plan parameter quality for robotic treatment.
∗∗∗CI = Conformity index (= patient volume receiving the prescribed dose / PTV volume receiving prescribed
dose)
and only for one patient considered clinically significant (see clinical scoring below).
AutoVMAT3mm performed significantly better for bladder Dmean, but the dierence in
the most important parameter, D1cm3 , was small (1%) and statistically insignificant (Table
4.1). Dierences in urethra dose parameters were statistically insignificant.
For all patients, the autoROBOT was superior regarding patient volumes receiving >5,
>10, >20, and >30 Gy (Table 4.1 and Fig. 4.3D), with percentage mean dierences of 12%
for V5Gy, 29% for V10Gy, 14% for V20Gy, and 5% for V30Gy. AutoVMAT3mm performed better
for patient volumes receiving >3 Gy, with mean percentage improvement of 12%.
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Figure 4.2 shows axial dose distributions for patient 17, who demonstrated the largest
advantages for autoROBOT in rectum plan parameters compared to autoVMAT (see also
Fig. 4.3B), and for patient 13, with the largest rectum advantages for VMAT. Apart from a
better rectum sparing, in patient 17, autoROBOT plan also showed better dose confor-
mality, in agreement with Fig. 4.3D.
All autoROBOT and autoVMAT3mm plans were clinically acceptable for the participating
clinician. The comparisons as presented in the upper panel of Fig. 4.4, are in line with
the plan parameter evaluations above. PTV doses were found of equal quality for all
patients. Apart from one patient with a small advantage for autoVMAT3mm, rectum dose
was considered equal or superior for autoROBOT. For bladder there was a balance, with
only equal plan quality or small dierences scored. For the urethra, the clinician had
a slight preference for the autoROBOT. Overall, for 13 patients the clinician preferred
autoROBOT, for 2 patients he preferred the autoVMAT3mm plan, and for 5 patients he
scored equal quality.
autoROBOT
autoROBOT
autoROBOT autoVMAT3mm
autoVMAT3mm
autoVMAT
autoVMAT5mm
autoVMAT5mm
Figure 4.2: Axial dose distributions for autoROBOT, autoVMAT3mm and autoVMAT5mm, for patients 17 (upper
panels) and 13 (lower panels). These patients demonstrated the most pronounced advantage in rectum dose
for autoROBOT instead of autoVMAT (patient 17), and the most pronounced advantage using autoVMAT
compared to autoROBOT (patient 13) (see also Figure 4.3B and 4.3F). Red contour = PTV (3 mm or 5 mm),
orange contour = rectum , blue contour = bladder and yellow contour = urethra.
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AutoROBOT vs AutoVMAT3mm AutoROBOT vs AutoVMAT5mm
(CC)
Figure 4.3: For all 20 patients, dierences between autoROBOT and autoVMAT3mm (left panels), or
autoVMAT5mm (right panels), expressed as ±|autoVMAT − autoROBOT | with positive values representing
better quality for autoROBOT. For dose bath percentage dierences as ±|100 ∗ (VMAT − ROBOT)/VMAT | are
expressed to compensate for dierences in volumes [cc] range between parameters. CI=conformity index (=
patient volume receiving 38 Gy/PTV receiving 38 Gy)
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4.3.2.2 autoROBOT vs. autoVMAT5mm
While for autoROBOT and autoVMAT3mm, a PTV coverage ≥95% was obtained for all
20 patients, with autoVMAT5mm this was only achieved for 2 patients, due to OAR con-
straints. 7 other patients obtained a clinically still acceptable coverage between 95% and
93%, while for the remaining 11 patients coverage was clinically unacceptable (<93%),
with a minimum of 88.8%. Also the near–minimum PTV doses were lower in the autoVMAT5mm
plans, while the CI was higher.
Notwithstanding the lower PTV coverage for autoVMAT5mm, rectum sparing was also
unfavorable compared to autoROBOT, with mean percentage dierences of 13% for rec-
tum D1cm3 , 69% for V60GyEq, 58% for V40GyEq and 32% for Dmean. Dierences in bladder and
urethra plan parameters were statistically insignificant. Dose bath was also favorable
for autoROBOT plans, with reductions of patient irradiated volumes of 19% for V5Gy, 37%
for V10Gy, 25% for V20Gy, and 18% for V30Gy. V3Gy was 5% lower for autoVMAT5mm, but this
was not statistically significant. Details on the comparisons between autoROBOT and
autoVMAT5mm are presented in the right part of Table 4.1 and Figs. 4.3E-H. Favorable plan
quality for autoROBOT compared to autoVMAT5mm is also observed in Fig. 4.2 (right pan-
els) and superiority of autoROBOT was also confirmed by the clinician scoring (Fig. 4.4,
lower panel).
For all 20 patients, the overall quality of the autoROBOT plans was considered better
than for autoVMAT5mm. For 11 patients, the clinician expected a real clinical impact of
choosing the autoROBOT plan instead of the autoVMAT5mm plan, for other 8 patients a
possibly important impact was expected, and for 1 patient a quality gain with probably
low impact was scored.
4.3.2.3 Dosimetric QA
All plans passed the QA tests, with average gamma passing rates of 98.7±0.6% for
autoROBOT, 99.8±0.2% for autoVMAT3mm and 99.6±0.8% for autoVMAT5mm.
4.4 Discussion
In this study, we have presented the first system for fully automated generation of
clinically deliverable treatment plans for a commercial robotic treatment unit. Auto-
mated planning, including non–coplanar beam angle selection, showed to improve plan
quality, compared to manual planning. With equal PTV coverage, autoROBOT plans were
superior to manual plans for all patients in sparing of the rectum and bladder, with neg-
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AutoROBOT
AutoROBOT
AutoROBOT
AutoROBOT better AutoVMAT better
t
t
AutoROBOT
t better AutoVMAT betterAutoROBOT better
AutoVMAT3mm
AutoVMAT5mm
Figure 4.4: Visual Analogue Scale (VAS) used for blind side–by–side plan comparisons by the treating
clinician, and clinician scoring with the values representing numbers of plans (for each line, the sum values
equal to 20).
ligible (but still superior) dierences for all other clinical requirements. These findings
are in line with results that we obtained on automated planning for regular linacs, using
a similar approach for automatic plan generation, see M&M section and [38, 155, 185, 186].
Apparently, interactive, manual planning is so complex and dependent on the planners’
skills and allotted planning time, that an optimal planning solution can often not be
guaranteed. The applied wish–list approach for automated planning features for each
individual patient a systematic search for finding the dosimetric parameters of a Pareto–
optimal plan with clinically desirable trade–os between all objectives. A commercial
planning system is then used to realize a clinically deliverable plan, using the attained
plan parameters as constraints, without any further trial–and–error planning. As de-
scribed in [22] and the supplementary material, a wish–list for a treatment site is devel-
oped based on the clinical treatment protocol and a few (typically 5) plans of recently
treated patients. A wish–list configuration entails repeated automatic plan generations
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for the 5 patients, each time followed by an update of the wish–list that aims at a still
higher plan quality in the next iteration. This iterative process is stopped if further im-
provements are considered not feasible. Specifically advantageous for autoROBOT plan-
ning, the upfront knowledge of feasible constraints allows the use of high resolution
optimization grid in the commercial TPS for generating the deliverable plan.
Also for other systems, improvements in VMAT/IMRT plan quality by using automated
planning have been reported [53, 64]. Nelms et al [124] observed large plan quality vari-
ations between 125 manual planners from various institutes, even with a very detailed
and quantitative description of planning goals. Berry et al. showed large inter–planner
variations in quality of plans that were manually generated within a single institution.
Automated planning assisted in reducing the variations [12, 13]. Clearly, further inves-
tigations on inconsistencies in manual planning and the potential role for automated
planning are warranted.
Strong points of our comparison of robotic surgery with VMAT for prostate SBRT are i)
the use of validated automated multi–criterial planning for both techniques (validation
by systematic comparison with manual planning, see [185] for autoVMAT and the Results
section for autoROBOT), ii) the use of the same TPS and exactly the same optimization
scheme for initial plan optimization for the two techniques (wish–list, see M&M section).
Due to these features, a bias–free comparison between robotic treatment and VMAT
could be made, based on consistent, high quality plans.
Technique comparisons were performed using dosimetric (DVH) evaluations and by
blind side–by–side plan scoring by the clinician responsible for prostate SBRT in our
center. The clinician scoring has important added value compared to dosimetric analy-
ses only, as it gives integrated views, considering the full dose distribution to OARs and
PTV and the global clinical quality of the plan for each individual patient. In a clinical
setting, a clinician would never accept a plan comparison that is only based on DVH
parameters.
AutoROBOT plans showed significant advantages compared to autoVMAT, both in the
DVH analyses and the clinician’s scoring. This was found for equal, 3 mm, CTV–PTV mar-
gins, and even stronger when comparing autoROBOT plans with 3 mm margin with au-
toVMAT plans with 5 mm margin. For 11 of the 20 patients, the autoVMAT plan with 5 mm
margin was clinically unacceptable because of low PTV coverage (<93%). On top of that,
rectum, bladder and urethra doses were significantly higher compared to autoROBOT.
For all patients, the autoROBOT plan had a largely reduced dose bath compared to both
autoVMAT3mm and autoVMAT5mm. The latter may especially be important for avoidance
of secondary tumors in the increasing fraction of younger prostate cancer patients, re-
lated to PSA screening.
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A limitation of the study is that we did not clinically compare robotic treatment with
VMAT, as needed for final conclusions, which we considered out of the scope of this pa-
per. Another (practically unavoidable) limitation is that the autoVMAT and autoROBOT
plans were calculated with dierent dose calculation engines as implemented in the
corresponding TPS. Although both systems were thoroughly tested prior to clinical in-
troduction, this might cause some bias in the comparisons.
Neither of the two recent studies that compared robotic treatment and VMAT for prostate
SBRT [102, 107] observed the potential of a large plan quality improvement for robotic
treatment, as observed in our study. Both the manual planning and retrospective plan
comparisons, as used in these studies, may have introduced bias in the technique com-
parisons. MacDougall et. al. [107] used a 3 mm CTV–PTV margin for robotic treatment
and a 5 mm margin for VMAT, and found no discernible dosimetric dierences based on
only 6 patients. Lin et. al. [102] used a 3 mm margin for robotic treatment and for VMAT
5 mm in all directions, except 3 mm in posterior direction. They concluded that VMAT
was preferable because of reduced treatment time and superior dose distribution con-
formality. The study showed however large and systematic dierences between robotic
treatment and VMAT in PTV dose inhomogeneity and PTV coverage, which could have
influenced the conclusions.
Dong et. al. compared VMAT with non–coplanar treatment at a C–arm linac [43], using
with the 4π non–coplanar delivery approach involving both gantry rotations and couch
displacements. For both techniques, the CTV–PTV margin was 5 mm with a reduction to 3
mm towards the rectum. As in our study, they observed clear plan quality advantages for
non–coplanar treatment compared to coplanar VMAT. Automated plan generation was
however only used for the non–coplanar planning, which could possibly have introduced
some bias in the comparisons, favouring non–coplanar treatment. For robotic couch
translations and rotations, Linthout et. al. [103] observed patient motion of up to 3 mm
and 2 degrees. Nonetheless, Dong et. al. [43] used the same CTV–PTV planning margin
for VMAT and non–coplanar treatment, possibly resulting in some study bias in favour
of non–coplanar linac treatment. In our study, we investigated isotropic 3 mm and 5 mm
CTV–PTV margins for autoVMAT. As our autoROBOT plans were already superior to VMAT
with isotropic 3 mm margins, the same (and probably to a larger extent) is expected to
hold for 5 mm margins with a reduction to 3 mm towards the rectum.
Delivery times of the autoROBOT plans generated in this study were around 45 min
(M&M section), as used in our clinical practice for treatment with an IRIS variable aper-
ture collimator, while VMAT treatments times were much shorter (∼8-10 min). Most of
the VMAT5mm plans were clinically unacceptable, and robotic treatment would anyway
be preferable, also with the prolonged treatment time. For the other VMAT5mm plans,
quality gains with robotic have to be weighed against the prolonged treatment dura-
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tion. The same holds for VMAT3mm plans, that might be applicable at linacs with novel
systems for intra–fraction motion correction [82, 194]. In this study, we have generated
robotic plans for the variable aperture IRIS collimator. Currently, an MLC is available for
the investigated robotic treatment unit [10, 59], probably resulting in reduced delivery
times [75, 79, 115, 190].
As described in the M&M section, for robotic prostate SBRT plans, we try to mimic HDR
brachytherapy dose distribution with intentionally inhomogeneous PTV dose delivery,
with high peak doses inside the PTV. The urethra dose is minimized by dose–volume
constraints. As the robot corrects for rotational tumor displacements, no PRV planning
margin around the urethra is clinically used. C–arm linacs are not equipped with a system
for rotation correction, implying that a PRV margin around the urethra may be needed for
the inhomogeneous dose distributions studied in this paper. This could then possibly
result in an enhanced percentage of patients with an unacceptably low PTV coverage.
The need and implications of the use of a urethra PRV margin at a C–arm linac have not
been investigated in this study.
4.5 Conclusion
The first system for fully automated generation of clinically deliverable plans for non–
coplanar robotic treatment has been presented. The system features multi–criterial
beam profile and beam angle optimization, resulting in plans with clinically favourable
trade–os between all treatment aims. For prostate SBRT, clinically acceptable, high
quality plans could be generated that highly outperformed manually generated plans.
Automatically generated robotic plans had consistently higher quality than automat-
ically generated plans for VMAT at a linac. Further research on improvement of plan
quality and plan consistency, including the role of automated planning, is warranted.
Supplementary material
Wish-list generation for prostate SBRT
For each patient, Erasmus-iCycle automatically generates a Pareto optimal plan with
clinically favourable trade-os between treatment objectives. Input for Erasmus-iCycle
plan generation is a contoured CT–scan and a wish–list.
A wish-list contains the hard constraints, which always need to be fulfilled in plan
generation, and treatment objectives with assigned priorities. Objectives are planning
aims that need to be met as closely as possible (or superseded, if possible). Starting
with the highest priority, the objectives in the wish–list are sequentially minimized, each
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time followed by adding the attained objective value as a novel constraint for the next
optimization problem to ensure that high priority goal values will not be deteriorated
in the minimization of lower priority objective functions ([21] and [22] for more details).
The wish–list is generated in an iterative procedure, starting with a first ’guess’ of the
wish-list by an experienced planner. This wish–list is then used for automated plan
generation for a small group of (5-10) patients, followed by plan evaluation to update
the wish–list for plan generation in a next iteration. This process with repeated wish–
list updates stops if no further enhancement of plan quality is feasible. For groups of
patients (e.g. all prostate patients treated with SBRT) this list is fixed, i.e. for all patients
in the group the plan is fully automatically generated with the same wish–list.
As described in more details in the Material and Methods section, in this study, two ver-
sions of Erasmus–iCycle were used, one for non–coplanar plan generation for a robotic
system equipped with a variable aperture collimator, the other for VMAT pre–optimization
for an Elekta linac with MLC. Using the above described iterative procedure in parallel
for the two Erasmus–iCycle versions, a single wish–list was generated for both robotic
and VMAT pre–optimization.
Table 4.2 shows the wish–list used for all robotic and VMAT automated plan genera-
tions. All applied constraint and objective convex functions were used for the automated
multi–criterial plan generation. These functions were selected to generate plans in line
with the (not always convex) clinical planning aims (see Plan Evaluation comparison in
M&M). The SE function (Sum of Exponentials) defined by Eq. 4.1 is basically a sum of ex-
ponentials of dierences between attained voxel doses dj and Dc , a user–defined critical
dose.
SE =
1
m
m∑
j=1
eα (dj−Dc ) (4.1)
where m is the number of voxels in the structure and α is the sensitivity parameter.
For tumors, the parameter α is positive, and SE is equal to the Logarithmic Tumor Con-
trol (LTCP), as introduced by Alber & Reemtsen [1], with Dc equal to the prescribed tumor
dose. The attractive characteristic of SE is that tumor underdosage is heavily penalized,
while overdose has a relatively low impact on the function value. In Table 4.2, SE is used
in priorities 1 and 2 to obtain clinically favourable PTV dose distributions. To limit for
each patient both positive and negative deviations from the clinically requested 95%
PTV coverage (V100%=95%), the goal value for SE in priority 1 is set automatically (Table
4.2). To this purpose, for priority 1, two plans are first generated with relatively small and
large goal values, respectively. For both plans, the PTV coverage is then calculated and
the final goal value for SE is determined by exponential interpolation. The aim of SE in
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priority 2 is creating a large dose inhomogeneity in the PTV like in HDR brachytherapy.
For prostate SBRT, it is extremely important that especially the high doses in rectum
and bladder are avoided as much as possible. To this purpose, a SE function with nega-
tive α is used in priorities 4 and 5, highly favouring avoidance of doses higher than the
defined critical values Dc (Table 4.2). SE = SE (Sum of Exponentials), defined in Eq. 4.1.
Constraints
Structure Type Limit Parameter
PTVopt maximum 61.5 Gy
Rectum maximum 36.5* Gy
Rectum gEUD 28 a = 20
Rectal Mucosa maximum 27 Gy
Overlap(Rectum,PTV+3mm) maximum 38 Gy
Bladder maximum 39.5 Gy
Bladder gEUD 30.7 a = 20
Overlap(Bladder,PTV+3mm) maximum 41.8 Gy
Urethra maximum 50 Gy
Urethra gEUD 39 Gy a = 3
Penis Scrotum maximum 1.5 Gy
Shell 3 mm from PTV maximum 38 Gy
Shell 3 cm from PTV maximum 20 Gy
Entrance dose** maximum 20 Gy
Objectives Parameters
Priority Structure Type Goal (Dp , α , sucient)
1 PTVopt SE optimized*** (37 Gy, 0.9,as goal)
2 PTVopt SE 2.2 (57 Gy, 0.07, 2.2)
3 CTV minimum 34 Gy sucient = 34 Gy
4 Rectum SE 0 Gy (28 Gy, -0.3)
5 Bladder SE 0 Gy (34 Gy, -0.1)
6 Rectum mean 0 Gy
7 Bladder mean 0 Gy
8 Urethra mean 0 Gy
9 Dose bath**** maximum 15 Gy
10 Left Femur head maximum 24 Gy
10 Right Femur head maximum 24 Gy
Table 4.2: Applied wish-list for all study patients. *Maximum dose constraints were set lower than clinical
requirements to account for voxel sampling for the optimizations. **Dose in 2 cm thick layer inside the body
contour. ***Values are automatically set to ensure a PTV coverage of 95%, if feasible within the constraints,
see text. ****Dose in patient volume in between shells at 3 cm from the PTV and 2 cm from the body contour.
PTVopt = PTVopt is the PTV excluding overlaps with rectum, bladder and urethra. gEUD = Generalized
Equivalent Uniform Dose [127]. SE = Sum of exponentials
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Abstract
Object: To explore the use of automated planning in robotic radiosurgery of benign
vestibular schwannoma (VS) tumors for dose reduction outside the planning target vo-
lume (PTV) to potentially reduce risk of secondary tumor induction.
Methods: A system for automated planning (AUTOplans) for VS patients was set up. The
goal of AUTO- planning was to reduce the dose bath, including the occurrence of high
dose spikes leaking from the PTV into normal tissues, without worsening PTV coverage,
OAR doses, or treatment time. For 20 VS patients treated with 1x12 Gy, the AUTOplan was
compared with the plan generated with conventional, manual trial-and-error planning
(MANplan).
Results: With equal PTV coverage, AUTOplans showed clinically negligible dierences
with MANplans in OAR sparing (largest mean dierence for all OARs: ∆D2% = 0.2 Gy). AU-
TOplan dose distributions were more compact: mean/maximum reductions of 23.6/53.8%
and 9.6/28.5% in patient volumes receiving more than 1 or 6 Gy, respectively (p<0.001).
AUTOplans also showed smaller dose spikes with mean/maximum reductions of 22.8/37.2%
and 14.2/40.4% in D2% for shells at 1 and 7 cm distance from the PTV, respectively (p<0.001).
Conclusion: Automated planning for benign VS tumors highly outperformed manual
planning with respect to the dose bath outside the PTV, without deteriorating PTV cove-
rage or OAR sparing, or significantly increasing treatment time.
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5.1 Introduction
Stereotactic radiosurgery is an increasingly used option for management of patients
with benign vestibular schwannoma (VS) tumors [9, 20, 122, 147, 188]. However, an in-
creased risk of secondary tumor formation associated with radiation exposure is well
established [8, 118, 128, 140, 154]. Therefore, in radiotherapy, dose outside the planning
target volume (PTV) should be avoided as much as possible, especially for patients with
a long life expectancy.
High delivery accuracy can be obtained with the robotic system due to real-time image-
guided tracking, allowing small PTV margins [46, 60], and non-coplanar treatment [143].
Currently, treatment plans in radiotherapy are generally generated in an interactive
trial-and-error process in which the planner tries to steer the treatment planning system
(TPS) towards generation of an acceptable solution ("manual planning"). This may be a
time consuming process and the resulting plan quality may heavily depend on the skills
and experience of the planner and on the available planning time and software. The
potential of automated treatment planning for both enhancement of plan quality and
drastic reduction in planning time, as alternative to manual planning, has been shown
in many studies [19, 22, 92, 116, 145, 169, 170, 180, 185, 199].
However, the existing literature on automated planning is focused on reduction of high
doses in OARs or enhancement of PTV dose. To the best of our knowledge, this is the first
study focusing on the use of automated planning for overall reduction of dose bath. The
study was inspired by observing the inability, in manual planning, to optimally reduce
the dose bath, and the planning time investment in getting a possible improvement, as
systematically tried.
In our institution, a system for fully automated, multi-criterial treatment plan gener-
ation has been developed, including optimization of beam directions. For this study,
this system was used as a pre-optimizer for the clinical TPS, that comes with the robotic
treatment unit to automatically generate deliverable plans for VS patients (AUTOplan).
We investigated whether automated planning could reduce the dose bath compared to
manually generated plans (MANplan), while not deteriorating dose delivery to the PTV
or OARs, and keeping treatment times comparable.
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5.2 Materials and methods
5.2.1 Patients and manual planning (MANplan)
Contoured CT scans of 20 vestibular schwannoma patients, previously treated at our
department with the CyberKnife (CK) robotic treatment unit (Accuray Inc, Sunnyvale,
USA), were included in the study. All patient-related information was fully anonymized
prior conducting the research. According to the regulations of the Ethics Committee of
Erasmus MC no ethical approval for this retrospective study was needed as there was
no impact on treatment and the applied patient data.
The gross tumor volume (GTV) was defined as the volume of contrast enhancement
on the T1-weighted MRI, after CT/MRI fusion. No margins were applied for planning (GTV
= PTV). The average tumor size was 2.9 cc (1.0-7.3 cc). Delineated OARs were brainstem,
trigeminal nerves, area of virtual facial nerve, optic nerves, chiasm, cochlea (when cli-
nically relevant), pituitary gland, and eyes.
For planning, tumor coverage (>98% of the volume receiving 100% of the prescribed
dose) had highest priority, while strictly fulfilling OAR Dmax constraints and high dose
conformality around the target. Furthermore, the goal was to maximally reduce the dose
bath, including minimizing dose spikes. Various planning strategies were clinically used
to control this dose spillage, based on planners’ preferences and experience. All MAN-
plans were generated in Multiplan[151] clinical TPS (Accuray Inc, Sunnyvale, USA) that
comes with the CK, with the Iris variable aperture collimator [47], avoiding diameters
smaller than 10 mm and larger than 40 mm. CK full head node path was used for a total
179 non-coplanar available beam directions.
Patients were treated with a single fraction of 12 Gy, prescribed at the 80% isodose.
5.2.2 Automated planning (AUTOplan)
Clinically deliverable CK plans for VS patients were generated in a two-step process:
i For each patient, a pre-plan was automatically generated with the in-house devel-
oped Erasmus-iCycle TPS [22, 145, 155, 185]. Plan generation with Erasmus-iCycle is
driven by a so-called wish-list, describing all planning constraints and objectives.
The latter have ascribed priorities for steering the multi-criterial plan generation,
resulting in clinically favorable trade-os between all treatment objectives. Gen-
erated plans are Pareto-optimal. For this study, a wish-list was made for VS plan
generation, minimizing dose spillage from the PTV while not deteriorating PTV
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and OAR dose, or substantially increasing the treatment time. Erasmus-iCycle and
wish-list building have been extensively described in the literature [22, 143].
ii The Erasmus-iCycle plan generated in step i was used to automatically create a
patient-specific planning template for subsequent automatic plan generation by
the clinical TPS Multiplan. The planning template contained the planning con-
straints to ensure generation in Multiplan of a clinically deliverable plan that mim-
icked the original Erasmus-iCycle plan.
This two-step approach was developed as for practical and regulatory reasons Erasmus-
iCycle cannot be used directly for clinical plan delivery.
A similar two-step approach is currently clinically used at Erasmus MC for automated
VMAT planning for prostate cancer, head and neck cancer, cervical cancer, and advanced
lung cancer, using the Monaco clinical TPS (Elekta AB, Stockholm, Sweden) in the sec-
ond step [185]. A distinct dierence between VS autoplanning for robotic treatment and
automated VMAT planning is the inclusion of non-coplanar beam-angle selection for VS.
All generated AUTOplans were based on the same planning protocol, the same choice
from Iris collimators, node set, and the same dose prescription as used for clinical MAN-
plan generation (above).
To minimize dose spillage in AUTOplans, the template for automated planning with
Multiplan (step ii above) contained individualized Dmax constraints for shells at dis-
tances of 1, 3, and 5 cm from the PTV. For each patient, these shell constraints were
obtained from the Erasmus-iCycle plan, generated in step i . In Erasmus-iCycle, the max-
imum doses at these shells were minimized, while respecting all hard planning con-
straints and the (higher) priorities for adequate PTV coverage and OAR sparing. AUTO-
plan generation in Multiplan in step i i was performed in high resolution with intensive
treatment time reduction.
5.2.3 Automated planning with fixed shell constraints
As described above, individually optimized shell constraints, derived from the Erasmus-
iCycle plan, were used in the second step of AUTOplan generation with the Multiplan TPS.
In an additional analysis, we investigated whether it was possible to use for all patients
the same Dmax constraints instead of patient-specific values. This study was performed
to understand how patient-specific constraints impact plan quality, keeping all other
parameters the same, or, opposite, to see if it was possible to use equal values for all
patients without losing in plan quality.
For each shell, the population-fixed constraint was calculated as the average of the
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patient-specific Dmax values found in the Erasmus-iCycle plans of the 20 study patients.
Then, for each of the patients, a second AUTOplan was generated, using the fixed con-
straints. In the remainder of the paper, the second AUTOplans with fixed constraints are
referred to as fAUTOplans.
5.2.4 Plan comparisons
Prior to comparisons of AUTOplans with MANplans and fAUTOplans with AUTOplans all
plans were rescaled to a tumor V12Gy of 98%, when achieved (in line with the clinical
planning protocol). Plans were compared using OAR near-maximum doses, D2%, confor-
mity index (CI), and treatment time. To evaluate dose bath and spikes, patient volumes
VD with D up to 10 Gy were assessed, as well as D2%, of shells from 1 to 7 cm away from
the tumor, for spillage. Two-sided Wilcoxon signed-rank tests were used to analyze plan
dierences, using p<0.05 for statistical significance.
5.3 Results
5.3.1 AUTOplan vs. MANplan
All MAN- and AUTOplans were clinically acceptable with tumor coverage>98% (98.3±0.1%)
while fulfilling all OAR constraints (Table 5.1). Treatment times were comparable; 36.1±5.0
min and 38.2±4.1 (p = 0.008) for MAN- and AUTOplans, respectively, allowing plan com-
parison without unacceptable treatment time dierence bias.
CIs for AUTOplans (1.16±0.06) were slightly better than for MANplans (1.18±0.09), but
the dierence was not significant (p = 0.4).
As for PTV coverage, MAN- and AUTOplans were comparable in terms of OARs sparing.
For all OARs, the mean dierence in near-maximum dose was below 0.2 Gy and statis-
tically not significant. Only the brainstem Dmean was on average slightly lower for the
AUTOplans, which was statistically significant, 2.2±0.7 Gy vs. 2.4±0.8 Gy, p=0.02.
Dose bath was substantially reduced in the AUTOplans (see Fig 5.1 for example). Both
patient volumes receiving dose and dose spikes were reduced with autoplanning com-
pared to manual planning. For most patients, volumes VD receiving more than D Gy
were smaller in the AUTOplans, as visible in the upper panel of Fig 5.2 and Table 5.1.
Population-average percentage VD reductions for D = 1, 2, 3, 6, 8, and 10 Gy were 23.6%,
17.5%, 15.3%, 13.5%, 9.6%, 6.1% and 2.9%, respectively (all p<0.005, apart from V10Gy with
p = 0.06). AUTOplans also had reduced near-maximum doses in the shells at 1, 2, 3, 5
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and 7 cm from the PTV, mostly reflecting smaller spikes and closer to the tumor. Aver-
age reductions of shell D2% with AUTOplans were 22.8%, 20.5%, 16.8%, 16.7% and 14.2%,
respectively (all p<0.001), as visible in the lower panel of Fig 5.2 and Table 5.1.
AUTOplans used less MU (4899 vs. 5716) and nodes (56.1 vs. 66.6), but more beams
(161.7 vs. 121.8), all p<0.004.
AUTOplans MANplans
Mean ± SD Mean ± SD
PTV V12Gy 98.3 ± 0.1 98.3 ± 0.1 %
CI∗ 1.2 ± 0.1 1.2 ± 0.1
Brainstem D2% 9.7 ± 1.5 9.8 ± 1.4 Gy
Dmean 2.2 ± 0.6 2.4 ± 0.8 Gy
Trigeminal Nerve D2% 11.7 ± 1.0 11.8 ± 0.8 Gy
Facial Nerve D2% 14.0 ± 0.2 14.0 ± 0.3 Gy
L Optic Nerve D2% 0.1 ± 0.0 0.2 ± 0.1 Gy
R Optic Nerve D2% 0.1 ± 0.0 0.2 ± 0.1 Gy
Chiasm D2% 0.3 ± 0.1 0.3 ± 0.1 Gy
Cochlea D2% 11.6 ± 1.2 11.8 ± 1.1 Gy
Pituitary D2% 0.3 ± 0.1 0.4 ± 0.1 Gy
L Eye D2% 0.1 ± 0.0 0.1 ± 0.0 Gy
R Eye D2% 0.1 ± 0.0 0.1 ± 0.0 Gy
Patient V1Gy 271.2 ± 142.9 347.6 ± 162.5 cc
V2Gy 68.0 ± 32.2 84.7 ± 44.8 cc
V3Gy 36.2 ± 16.6 44.0 ± 22.9 cc
V4Gy 24.1 ± 10.9 28.8 ± 14.9 cc
V6Gy 14.3 ± 6.5 16.2 ± 8.3 cc
V8Gy 9.6 ± 4.6 10.3 ± 5.3 cc
V10Gy 6.2 ± 3.3 6.4 ± 3.4 cc
PTV Shell 1cm D2% 3.7 ± 0.5 4.9 ± 0.8 Gy
PTV Shell 2cm D2% 2.0 ± 0.4 2.6 ± 0.5 Gy
PTV Shell 3cm D2% 1.4 ± 0.3 1.7 ± 0.3 Gy
PTV Shell 5cm D2% 1.0 ± 0.2 1.2 ± 0.2 Gy
PTV Shell 7cm D2% 0.8 ± 0.2 1.0 ± 0.2 Gy
Treatment Time 38.2 ± 4.0 36.1 ± 4.8 min
MU 4899 ± 704 5716 ± 996
Nodes 56.1 ± 10.8 66.6 ± 21.1
Beams 161.8 ± 24.2 121.8 ± 29.6
Table 5.1: For all 20 patients, mean values for automatically generated plans (AUTOplans) and manually
generated (MANplans). Bold values represent the statistically significant dierences as p<0.05 with the
Wilcoxon’s signed-rank test.∗CI = Conformity Index.
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Figure 5.1: Axial dose distributions for an example patient. The AUTOplan (right) shows a reduced dose bath,
with also smaller dose spikes, than the MANplan (left). Reduction in brainstem dose is also visible. (Red
contour = PTV, pink contour = Brainstem.)
Figure 5.2: Dierences between AUTOplans and MANplans in dose spillage. Positive dierences reflect higher
quality for the AUTOplan. Upper panel: dierences in patient volumes receiving more than 1, 2, 3, ..., 10 Gy.
Lower panel: dierences in D2% for shells at 1, 2, ..., 7 cm away from the tumor. For the individual patients,
dierences were calculated as (MANplan − AUTOplan)/MANplan ∗ 100. The last column shows population
mean dierences and their statistical significance marked with * (p<0.05).
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5.3.2 fAUTOplan vs. AUTOplan
Table 5.2 shows for each patient the Dmax for the shells at 1, 3, and 5 cm from the PTVs,
as obtained from plan optimization with Erasmus-iCycle, and used as individualized shell
constraints in Multiplan optimization in the second phase of the AUTOplan generation.
The presented population mean values were used for all the patients to generate the
fAUTOplans.
Using population average shell constraints instead of the individualized constraints
(Table 2) for plan generation in Multiplan (fAUTOplan) resulted in an unacceptable PTV
coverage for 5 out of 20 patients (Table 5.2, patients 14, 16, 18, 19 and 20), with a minimum
of 92.3% instead of 98%, due to too tight shell constraints.
For the remainder of the patients, with equal PTV coverage, there were no statisti-
cally significant dierences between fAUTOplans and AUTOplans in CI, mean and near-
maximum OAR doses, patient volumes VD receiving more than D Gy (D≤10 Gy), and D2%
at shells from 1-7 cm from the PTV.
5.4 Discussion
Several studies have observed superiority of automated plan generation compared to
conventional, interactive trial-and-error planning regarding enhancement of PTV dose,
or reduction of OAR doses [65, 92, 155, 185, 199]. Apart from plan quality advantages,
automated planning did always result in drastic reductions in planning workload.
Especially for patients with a long life expectancy, such as VS patients, dose outside
the PTV should be maximally avoided to reduce the risk for secondary tumor induction.
To the best of our knowledge, this is the first paper on automated planning that primarily
aims at the overall reduction of low and high doses outside the PTV of a benign tumor.
To this purpose, a system was set up and configured for fully automated non-coplanar
plan generation for robotic stereotactic treatment of VS patients.
The project was started after observing frequent problems with controlling or improv-
ing dose bath and spikes from the PTV in manual planning (see Fig 5.1a). In this study we
have demonstrated that automated planning could reduce the dose bath, without wors-
ening PTV coverage or OAR sparing, or substantially increasing treatment time. More-
over, due to the automation, there was no workload in the plan generation.
As explained in the M&M section, final AUTOplans were generated with the commercial
TPS that comes with the robotic treatment unit. Therefore, this TPS is indeed able to
generate highly compact plans, with minimal dose delivery outside the PTV and avoiding
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Patient-specific Shell 1 cm Shell 3 cm Shell 5 cm
constraints Dmax [cGy] Dmax [cGy] Dmax [cGy]
Pt 1 427 156 112
Pt 2 374 140 106
Pt 3 430 157 117
Pt 4 423 173 138
Pt 5 458 171 133
Pt 6 426 155 120
Pt 7 428 168 129
Pt 8 370 146 98
Pt 9 390 123 88
Pt 10 344 108 74
Pt 11 423 170 105
Pt 12 417 174 137
Pt 13 368 135 107
Pt 14 475 181 124
Pt 15 357 119 84
Pt 16 536 210 162
Pt 17 396 165 123
Pt 18 471 198 167
Pt 19 522 181 134
Pt 20 486 200 149
Mean±SD 426±53 162±27 120±25
Table 5.2: For each patient, Dmax values for shells at 1, 3 and 5 cm from the PTV as derived from the
Erasmus-iCycle plan, and population mean values with standard deviations. Patient-specific Dmax values
were used as constraints in AUTOplan generations, while the mean values were used for fAUTOplan
generation.
dose spikes. In the autoplanning procedure, the individualized shell constraints, used
in the commercial TPS to maximally avoid dose spillage, were automatically generated
using a pre-optimization with our in-house developed multi-criteria optimizer (step i ,
M&M section). In conventional manual planning, shell constraints are defined for each
patient in a trial-and-error procedure. Then, finding the optimal constraint values for
individual patients is often impractical, because it is too time consuming to be feasible
in clinical routine.
The presented workflow for AUTOplan generation of highly compact dose distributions
is likely to be applicable also for other benign tumors, which will be a topic for further
research.
To the best of our knowledge, this is the first study to systematically investigate a
possible reduction in dose bath while mantaining treatment technique. Integral dose
reduction is a reported outcome from many plan comparison studies [32, 48, 72, 131],
beside the OARs evaluation, as well as dierent metrics have been proposed [165, 200],
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reflecting the clinical relevance. However a systematic dose bath reduction can not be
easily investigated without a consistent planning work flow such as the one used in this
study, including the dose bath improvement without loosing quality in the PTV and OAR
dose distributions.
For 5/20 patients, the applied population-based, fixed shell constraints used for gen-
erating the fAUTOplan were too tight, resulting in an unacceptably low PTV coverage.
No correlation with PTV size or other features was found. For the other 15 patients, the
fAUTOplan was similar in quality as the AUTOplan. This does however not necessarily
imply that in clinical routine, acceptable high quality plans would have been generated
for the latter patients, using the fixed constraints. fAUTOplans were generated with an
automated planning workflow and it is uncertain whether using the population-based
constraints with manual planning would have resulted in high quality plans for these 15
patients. This could have been dependent on the complexity of the individual cases and
on the skills of the involved planners. Anyway, compared with automated planning, the
workload would have increased.
On the longer term and to serve the radiotherapy community, there is a clear need for
more advanced commercial treatment planning systems that are faster and/or facilitate
automated plan generation.
5.5 Conclusion
Compared to conventional planning, automated plan generation for robotic treatment
of patients with a benign vestibular schwannoma tumor could to a large extent reduce
low to high dose outside the PTV while maintaining acceptable tumor coverage and sim-
ilar OAR dose, and keeping delivery time comparable.
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Chapter 8
Discussion
In this thesis, automated treatment planning has been intensively used and investi-
gated, focusing on comparisons of coplanar and non-coplanar beam configurations and
on plan quality improvements relative to manual planning. In this Discussion chapter,
the focus will be on challenges that automated planning brings along in clinics and in
research, disputes on the use of non-coplanar beam geometries, and the benefits of
automated planning in treatment technique comparisons. To conclude, possibilities for
future research are discussed.
8.1 Challenges in autoplanning configuration
Configuration of an autoplanning workflow is a new concept in radiotherapy (RT). In
conventional manual planning, each plan is produced by itself in a trial-and-error ap-
proach, allowing multiple iterations with human interventions to fix undesired aspects
of intermediate dose distributions. Plan generation based on patient-group templates
is in the direction of autoplanning. These templates can enhance plan quality uniformity
and can speed up the planning process. However, in almost all cases, manual fine-tuning
of a template-based plan is necessary.
Ideally, autoplanning results for all patients in the final acceptable high-quality plan,
which should then also be Pareto-optimal. More realistically, for the vast majority of
patients there should be no need for manual fine-tuning of the autoplan. To come at
this point, proper configuration of the autoplanning algorithm is crucial.
In Erasmus-iCycle, configuration means generation of a wish-list [22]. The process of
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wish-list tuning is globally described in the Electronic supplement of [69]. A proper wish-
list can ensure that plans are generated in line with scientific knowledge, as well as local
treatment traditions, e.g. regarding the required level of overall high-dose conformality
vs. sparing of specific OARs. The configurations performed for the studies in this thesis
have resulted in the following observations:
i) Each wish-list determines the plan quality for an entire patient group. If the configu-
ration is suboptimal, the quality of all plans will be suboptimal, eectively introducing
a systematic problem. There is never a guarantee that the best possible wish-list will be
found, also because the best possible plan quality is generally not well defined. Com-
parison with manually generated, clinically delivered plans is a basic measure to ensure
that at least the clinical quality is obtained. However, as demonstrated in several studies
(also in this thesis, chapters 4, 5 and 6), extensive tuning generally results in a wish-list
that can beat clinical plan quality. Tuning of wish-lists is a complex, interactive pro-
cedure. As for manual planning for individual patients, it is not always clear when to
stop. Previous experience in generation of wish-lists is likely to ease the task and may
result in a better result. Important is also that enough time is reserved to obtain the
best possible result.
ii) A well-established treatment planning protocol, agreed upon by the treating clini-
cians, is crucial for proper wish-list tuning. However, these protocols can generally only
partly describe how optimal plans should look like, as it is virtually impossible to fully
quantify requirements for conformality, dose spikes, the dose bath, hot/cold spots, and
balances between all treatment objectives. It may also happen that during wish-list gen-
eration, dose distributions occur with characteristics that have not been encountered in
previous manual planning, making that the clinical planning protocol cannot be strictly
used as a guideline. As mentioned before, with proper wish-list tuning, the quality of
autoplans generated with Erasmus-iCycle can supersede that of manual plans. However,
the clinical planning protocol does generally not contain enough information to decide
on how to best use the extra room for quality enhancement, e.g. how should it be divided
between target and OARs, or how should it be divided among OARs, should it be used to
enhance conformality, etc. To overcome the unavoidable limitations of planning proto-
cols, it is essential to regularly discuss during the tuning process intermediate planning
results with the full planning team, including the radiation oncologists. The comments
of the clinicians can be used in further tuning iterations to shape plans according to
their needs.
iii) Current planning protocols generally allow flexibility in the performed manual plan-
ning to accommodate variations in planning objectives in a group of treating clinicians.
Autoplanning by itself does not have this flexibility. Therefore, configuration of the auto-
planning algorithm is often preceded by discussions between clinicians to better agree
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on what is actually desired. Agreement can also be obtained during the tuning process,
in discussions on how to improve the plans relative to current clinical planning. The
latter discussions may be easier as autoplanning may improve quality for all clinicians.
No agreement may in the end result in manual fine-tuning of part of the autoplans.
Fine-tuned autoplans are generally of higher quality than plans that were created with
manual planning from scratch. Moreover, fine-tuning is often a lot faster.
iv) During wish-list tuning it may appear that, compared to manual planning, a sub-
stantial quality gain can be obtained for an objective at the cost of a seemingly minor
loss for another. This may result in lengthy discussions because of diculty in accepting
a loss in quality compared to what one is used to since a long time, even if the loss is
small and the gain on other aspects is large.
v) Non-convex cost functions such as dose-volume constraints can result in unsta-
ble behaviour of optimizers when generating treatment plans. In manual planning, the
planner can observe this and try to correct for it. In autoplanning, such unpredictable,
unstable behavior can result in suboptimal plans. Therefore, in this thesis, non-convex
cost functions were avoided as much as possible in wish-list creation. A drawback of
this approach is that there may be a gap between functions used to optimize a plan,
and parameters used to clinically evaluate plans. E.g. in Chapter 4, D1cc dose-volume
requirements for both rectum and bladder were optimized using EUD cost functions in
autoplanning.
vi) In current practice, every new patient is considered as a new planning problem,
to be solved in a collaboration between the planner and the treating radiation oncolo-
gist. Obviously, there is time reserved for this per patient approach. For autoplanning,
a dierent workflow is required; prior to treatment of any patient, substantial time in-
vestments are needed for wish-list creation. After this investment, much less time is
needed for individual patients, as high-quality plans are automatically generated. The
upfront time investments are not part of the still mostly applied clinical workflow based
on manual planning, and it may be challenging to find time for the necessary meetings.
vii) Depending on the case complexity, automated plan generation may take longer
than manual planning. In return, there is often a higher plan quality, and there is no
manual workload involved. In clinical practice in our center, it is accepted that the plan
is available the day after starting the autoplanning run. Often it is available on the same
day. A cluster of servers is available for autoplanning 7 days per week, 24 hours per day,
and the planner receives an email when the plan is ready, avoiding the need of active
waiting and checking.
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8.2 Non-coplanar beam setups in clinical reality
In clinical practice, the spread/use and therefore the potential positive impact of non-
coplanar planning can be restricted. This can e.g. be related to 1) reluctance in moving
away from the more conventional coplanar setup that was used for many years, 2) doses
delivered to healthy tissues that are fully spared with coplanar approaches, 3) lack of
commercial treatment planning systems (TPS) for advanced non-coplanar BAO for treat-
ment at regular C-arm linacs, 4) increase in computation and/or treatment time, and 5)
potentially reduced delivery.
With the introduction of the robotic CyberKnife treatment unit, some of the perceived
issues with non-coplanar treatment could be resolved. It allows easy delivery of non-
coplanar beams without intensively moving the patient. Instead, the linac head moves
around the patient.
Nowadays, the dosimetric advantages of non-coplanar geometries have been broadly
acknowledged for intracranial tumors, where the solid angle with candidate beams can
be made large, as for many directions there is no risk of gantry-couch/patient collisions
[133]. For extracranial treatment, the matter seems more controversial [161]. There are
studies showing clear benefit of non-coplanar treatment; reduction of OAR doses [41–
44, 86, 143, 145, 184], improved conformality [153], reduced low-intermediate doses [45,
144], and opportunity for dose escalation [126, 146]. Other studies did not show a clear
dosimetrical benefit of non-coplanar setups, maintaining the enhanced complexity in
planning and delivery compared to coplanar geometry [30, 40, 160].
However, often the latter studies included few patients (8-10) and planning was per-
formed manually, including the complex selection of non-coplanar beam setups. E.g.
non-coplanar IMRT with 6 manually selected beams was compared to VMAT and To-
motherapy [160].
Conceptually, the coplanar beams form a subset of the full non-coplanar space. The
increased degree of freedom in planning by considering also non-coplanar beams can
theoretically only result in plans that are as least as good as coplanar plans. Manual se-
lection of non-coplanar beams may hamper observation of plan quality enhancements
[22, 95]. With the fully automated, integrated multi-criterial beam angle and profile op-
timization in Erasmus-iCycle, clear dosimetric advantages of optimized non-coplanar
beam setups were observed for prostate cancer patients (Chapters 2, 4 and 7), vestibu-
lar schwannoma (Chapter 5) and mediastinal lymphoma patients (Chapter 6).
(Largely) enhanced delivery times may be a prohibitive condition for the widespread
employment of non-coplanar beam setups. It makes treatments more expensive and can
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also result in reduced delivery accuracy. However, active research and eort have been
directed towards developing non-coplanar techniques [163]. Recently, the CyberKnife
was equipped with an MLC, resulting in 36% shorter treatment time compared to treat-
ment with the variable aperture IRIS collimator [79]. In a research setting, continuous
radiation delivery between CyberKnife nodes (CyberArc) has been explored, reducing de-
livery time by a factor of 1.5 or 2, depending on the plan, without plan quality deteriora-
tion [83]. For C-arm linacs, fully dynamic treatments, including gantry and couch motion
during dose delivery, have been explored [192]. Sharfo et al. proposed the VMAT+ treat-
ment approach, combining coplanar VMAT with a few non-coplanar IMRT beams [157].
For liver SBRT, VMAT+ resulted in largely enhanced dosimetric plan quality compared to
VMAT, with only modest increases in treatment time. In Chapter 7, VMAT+ was investiga-
ted for prostate SBRT and a non-coplanar beam angle class solution, consisting of only
two IMRT beams with fixed directions, was proposed for complementing VMAT. Again,
plan quality increased substantially compared to VMAT at the cost of only a moderate
increase in treatment time.
8.3 Reducing bias in treatment planning studies that com-
pare treatment techniques
Treatment planning entails solving a large and complex multi-criterial optimization
problem, with an infinite number of suboptimal solutions. Current conventional, ma-
nual planning is an interactive trial-and-error procedure, in which the planner tries to
steer the TPS towards an acceptable and hopefully high-quality plan. However, the final
plan quality is highly dependent on the planner’s skills, experience, and endurance, and
on allotted time. Moreover, the definition of plan optimality is to a large extent based
on the judgement of the planner, even in case of an existing detailed planning protocol,
and plan quality is also influenced by the planners’ judgements on whether or not more
iterations can result in a better plan. Apart from inter-planner variations in treatment
plans, there are also the well-known intra-planner variations, i.e. for the same patient,
the achieved quality may be dierent for dierent planning attempts. As every patient
deserves the best possible treatment, without being dependent on luck regarding the
assigned planner and the available planning time, planning should be optimized and
standardized as much as possible by reducing the impact of planners. Planning automa-
tion has shown major opportunities for plan quality improvement compared to manual
planning, together with workload reductions [38, 64–66, 69, 73, 114, 144, 145, 158, 185, 186].
Also in planning studies for comparing treatment techniques, manual planning can
potentially lead to suboptimal results.
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In order to assess whether a treatment technique is better than another, ideally the
final conclusion is only related to intrinsic technique dierences. In particular, there
should be no bias introduced by the performed treatment planning.
In bias-free technique comparisons based on planning, repeated planning should ide-
ally always result in exactly the same plans. In manual planning, one can be far from
this ideal situation (see above). Variations in plan quality can result in inconsistent treat-
ment technique comparisons, especially when variations in planning are in the order of
the quality dierences between the investigated techniques.
When treatment techniques are compared based on manually generated plans, a bias
can also be introduced by dierences in planning experience for the investigated tech-
niques, or a wish that one of the techniques will be superior. The latter may also occur if
the planner is aware of a desired output, and makes best eorts to avoid study bias. As
manual generation of high-quality treatment plans is time consuming, published treat-
ment planning studies are generally based on limited numbers of treatment plans. As
patient anatomies may be highly diverse, this can potentially also result in study bias in
treatment technique comparisons.
Apart from manual planning, also more technical issues can result in suboptimal tech-
nique comparisons. E.g. if delivery techniques are compared with dierent TPSs, there
is the risk of bias, as the TPSs used for the dierent techniques may not be equally
powerful.
Irreproducibility, inconsistency and suboptimality can also occur when (mathematical)
optimality conditions are not reached or converge to a local optimum as with the use
of non-convex cost functions (above), but this can also happen if cost functions are not
minimized to the full extent to reduce calculation times.
In this thesis, Erasmus-iCycle was used for treatment technique comparisons. In all
comparisons, exactly the same wish-list was used for all treatment plans and all tech-
niques, preventing a lot of the above described issues with bias, plan quality definition
and reproducibility related to manual planning. However, wish-list generation is basi-
cally a tuning process with many decisions to be made by the treatment team (see also
section 8.1 above). Importantly, all involved treatment techniques have to be evaluated
in the tuning process to avoid/reduce bias. Apart from consistency in plan generation,
autoplanning with Erasmus-iCycle also drastically reduces the involved planning work-
load. Therefore, the technique comparisons performed in this thesis could be based on
large numbers of treatment plans; 1500, 1060, 645 and 740 plans were generated for the
studies described in Chapters 2, 3, 6 and 7.
By using the same optimizer for all treatment techniques, the often observed bias
in published technique comparisons related to dierent TPSs for dierent techniques
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could be avoided. However, to investigate deliverable plans, in Chapters 4, 5 and 7,
fluence-optimized Erasmus-iCycle plans were converted into deliverable plans, by an
automatic mimicking of these plans in a commercial TPS. Care was taken that this mim-
icking went equally well for all techniques to avoid introduction of bias. In Chapter 4,
comparing CyberKnife with VMAT for prostate SBRT, the mimicking was performed with
dierent commercial TPSs, requiring an even larger focus on prevention of bias.
8.4 Future work
Validation of beam angle optimization (BAO) with Erasmus-iCycle
In this thesis, BAO as implemented in Erasmus-iCycle was used to investigate opportu-
nities for plan quality enhancement, and to compare coplanar and non-coplanar beam
configurations. BAO showed robust and consistent behaviour; plan quality increased
with increasing numbers of beams, and non-coplanar set-ups resulted in higher quality
than coplanar. Also the diculty in defining a beam angle class solution in Chapter 3
points at a high quality of the plans generated with BAO as implemented in Erasmus-
iCycle.
Erasmus-iCycle was also compared to another BAO algorithm not showing significant
dierences [181].
Based on available evidence at this time, it can be concluded that BAO in Erasmus-
iCycle behaves as expected and that it generally results in high-quality plans. On the
other hand, except from [181], formal plan quality assessments have not yet been per-
formed, and it would be good to do it. Such validation studies could e.g. be performed by
investigating variations in beam geometries from the ones selected by Erasmus-iCycle.
To this purpose, low weight beams, or the first selected beams could be removed, fol-
lowed by an automated selection of new beams from the pool of candidate beams. Sim-
ilarly, a local neighbourhood search could be performed, where a neighbour beam is
added to the beam geometry instead of a beam selected by BAO. For the VMAT+ approach
([157] and Chapter 7), selected non-coplanar beam geometries could be compared with
exhaustive search.
An interesting study would also be to compare Erasmus-iCycle BAO with the non-
coplanar beam orientation optimization used in studies on the 4π treatment approach
[41, 42].
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Further exploration of the VMAT+ concept
In [159] and Chapter 7, clear dosimetric benefits were found for complementing copla-
nar VMAT with a small set of non-coplanar beams. This novel VMAT+ treatment approach
allowed to substantially increase plan quality with respect to VMAT with only minor in-
creases in treatment time.
This is an important finding for the clinical routine, as plan quality could be substan-
tially improved without the use of many non-coplanar beams that would result in drastic
increases in delivery times
Therefore, there is an incentive to investigate the VMAT+ approach for more tumor
sites, including exploration of opportunities for the use of non-coplanar beam angle
class solutions with low numbers of beams to avoid the need for individualized BAO (see
Chapter 7). Treatment sites as mediastinal lymphoma (showing benefit of non-coplanar
configurations, Chapter 6), challenging head and neck cases, lung tumors, or intracranial
tumors would be good candidates for exploration of VMAT+.
Semi-automated wish-list generation
Automated planning with Erasmus-iCycle can be a powerful approach for improving
and standardizing plan quality and for reducing the planning workload. As described
in section 8.1 it does not come without challenges; plan generation is based on a wish-
list that is created in a complex trial-and-error tuning procedure, while a sub-optimal
wish-list translates into sub-optimal quality of all generated autoplans.
Currently, many trail-and-error iterations are performed in wish-list creation, together
with intensive discussions with the treating physicians in order to maximize the probably
that the best possible wish-list will be generated. The current tuning of wish-lists entails
large time investments while there is no guarantee for finding the best wish-list.
More ‘automation of the automation’ would be desirable and could be a topic of fur-
ther research, as discussed below.
Many plan requirements are equally present in dierent treatment protocols. For ex-
ample, in most of the protocols the PTV coverage comes as first priority within OAR con-
straints, and it is defined as V95% or 98% or 99% = 100%PD or 95%PD. This recurrent clinical
protocol requirement can be translated with fixed cost functions, known by experience
to be ecient.
Moreover, the tuning of some cost function parameters could possibly be automated,
letting the optimizer i) try automatically generate plans with a certain parameter value
for a group of patients, ii) automatically evaluate the planning results, iii) adapting the
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parameter values and iv) go back to i).
Another approach for partial automation of wish-list creation could be the develop-
ment and use of well-structured questionnaires to be filled out by planning team. Dif-
ferent dose distributions, generated with a starting-point wish-list or several version of
a wish-list, could be shown to the team, while asking questions on things they would
like to change or not, adapting the wish-list(s) consequently and so on.
Automated planning for personalized care
Nowadays, the applied treatment technique is generally fixed per tumor group, e.g.
treatment with VMAT at a C-arm linac or robotic therapy with a CyberKnife. However,
technique selection could also be made patient-specific, by comparing for each patient
treatment plans for the available treatment options. With automated planning this could
be performed with a minimum of bias and workload. Such patient-specific technique
comparisons could further personalize patient care. Currently, admission of a patient to
the scarce and more expensive proton therapy is in The Netherlands already based on
a comparison of a generated proton plan with a competing photon plan. Only in case of
sucient gain, the patient is referred to proton therapy.
At the same time, every patient comes with his/her own background and anatomy.
Therefore, even within a fixed treatment technique, generation of several plans with
dierent trade-os between the treatment objectives could potentially contribute to
improved patient care. In case of a comorbidity leading to an enhanced risk of radiation-
induced side eects (e.g. diabetes in prostate cancer patients, resulting in a substan-
tially enhanced risk for rectal toxicity), several plans could be generated to explore
trade-os between the target and the OARs. Technically, this type of approaches with
multiple plans per patient are now feasible and clinical testing is warranted.
Prioritized planning for coping with GTV delineation uncertainty and mi-
croscopic disease
Currently, the biggest geometrical uncertainties in radiotherapy are related to seg-
mentation of the Gross Target Volume (GTV) and establishment of margins for micro-
scopic disease to define the Clinical Target Volume (CTV). Involved decisions are nowa-
days binary, i.e. tissues are either inside the structures and then considered as tu-
mor during treatment plan generation, or they are outside and are then considered as
healthy tissue to be maximally spared. In many situations uncertainties on the GTV and
CTV boundaries may be large [183].
The multi-criteria prioritized optimization nature of Erasmus-iCycle could probably
help in moving away from this binary thinking, by defining ring structures around the
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delineated GTV contours and in areas with potential microscopic disease. By proper
selection of priorities of the objective functions used to steer dose delivery in these
rings, patient-specific balances could be made between radiation-induced toxicity and
risk of tumor miss. This could e.g. be used to enlarge the high dose volumes in areas
where high dose would not result in enhanced toxicity. Investigations to explore this
approach for several tumor types are warranted.
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In conventional, manual planning for IMRT, a planner has to make many choices to
drive the treatment planning system (TPS) towards generation of a high-quality plan. In
an interactive trial-and-error procedure, he/she has to carefully select the number of
beams, the beam directions, as well as the cost functions with their weights to define
an optimization problem that will result in a high-quality plan. Each problem definition
results in a treatment plan with unique trade-os between all treatment objectives, and
definition of the optimization problem that results in optimal trade-os is highly com-
plex. As a consequence, the quality of a radiotherapy treatment plan may be highly
dependent on the skills of the involved planner and on allotted planning time. This is
the case in a single plan generation for a patient, but it can also aect research studies
where plan comparisons are performed to compare treatment techniques.
Automated planning with our in-house Erasmus-iCycle optimizer has demonstrated
possibilities for consistent generation of high-quality plans, while fully avoiding manual
planning workload. As a unique feature, this system features integrated beam profile and
beam angle optimization (BAO).
In this thesis, Erasmus-iCycle was used to systematically investigate the impact of
beam configurations on plan quality, and to investigate plan quality improvements rel-
ative to conventional manual planning.
In Chapter 2, the BAO option was used to investigate relationships between plan qua-
lity and the beam angle search space, i.e. the set of candidate beam directions that may
be selected for generating an optimal plan. Ten prostate SBRT patients were included in
the study. Autoplans with up to 30 beams with individualized directions were generated
for 5 dierent candidate beam sets, one coplanar and four non-coplanar. The candidate
sets sets were: i) a coplanar set, covering the whole 360◦ range (CP), ii) all directions
(mainly anterior) available in the robotic CyberKnife treatment unit (CK), iii) a fully non-
coplanar sphere (F-NCP), i.e. also including posterior beams that were not present in
135
9
Su
m
m
ar
y
Summary
CK, and iv)/v) CK+ and CK++, as subsets of F-NCP, with higher beam density than the CK
beam set (CK+), or covering a (bigger) laterally extended beam area (CK++). In total 1500
plans were generated.
Generated plans were clinically acceptable, according to an assessment of involved
clinicians. All plans were generated with highly similar PTV coverages, allowing plan
comparisons to be based on OAR dose parameters, with the rectum considered most
important.
OAR sparing improved with all NCP configurations compared to CP, especially for the
rectum. F-NCP performed the best, with reductions in rectum Dmean, V40GyEq, V60GyEq and
D2% of 25%, 35%, 37%, and 8%, respectively, compared to CP. CK performed slightly worse
than F-NCP, which could be compensated by the laterally extended beam area in CK++.
Addition of posterior beams (CK++ → F-NCP) or enhancement of the beam density (CK
→ CK+) did not lead to further improvements.
Increasing the number of selected beams significantly improved plan quality. For
coplanar plans, for instance, rectum Dmean, V40GyEq, V60GyEq and D2% could be improved
by 39%, 57%, 64%, and 13%, respectively, when using 25 beams instead of 11 beams. Us-
ing more than 25 beams did not result in relevant further plan improvements.
With the clear benefit of non-coplanar Cyberknife beams for prostate SBRT as ob-
served in Chapter 3, the possibility of creating a non-coplanar beam angle class solu-
tion (CS) for Cyberknife was explored to replace the time-consuming individualized BAO,
while not losing in plan quality.
CS generation was performed in 3 steps, based on 10 training patients. First, Erasmus-
iCycle was used to generate plans with 15, 20, and 25 non-coplanar individualized beams.
Secondly, based on the beams selected in these plans, 6 recipes for creation of beam
angle CSs were investigated for all three beam numbers. Finally, Erasmus-iCycle was
used to generate plans for the fixed (6x3) CSs, both for the 10 training patients and for
20 independent validation patients. A total of 1060 plans was generated.
Out of the 6 tested CS recipes, only 1 resulted in 15-, 20-, and 25-beam non-coplanar
CSs without plan deterioration compared with individualized BAO. Negligible dierences
were found between 25-beam CS plans and 25-beam BAO plans, with mean dierences
in rectum rectum D1cc, V60GyEq, V40GyEq, and Dmean of 0.2 ± 0.4 Gy, 0.1 ± 0.2%-points, 0.2
± 0.3%-points, and 0.1 ± 0.2 Gy, respectively.
Dierences between 15- and 20-beam CS and BAO plans were also negligible. On the
other hand, computation times with the CSs were reduced by a factor of 14 to 25, due to
the avoidance of costly BAO.
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In Chapter 4, the first system for fully automated generation of clinically deliverable Cy-
berKnife treatment plans (autoROBOT) was developed and evaluated for prostate SBRT.
To this purpose, Erasmus-iCycle was coupled to the commercial CyberKnife TPS. The sys-
tem was first validated by comparing automatically generated CyberKnife plans with
manually generated plans. Next, for 20 patients, autoROBOT plans were compared to
VMAT plans, that were also automatically generated (autoVMAT). Both autoROBOT and
autoVMAT plans with CTV-PTV margins of 3 mm (as used in clinical prostate SBRT Cy-
berKnife routine) were generated. In addition, 5 mm CTV-PTV margin autoVMAT plans
were generated (a margin often applied for VMAT).
Compared to manual planning, autoROBOT improved rectum D1cc (16%), V60GyEq (75%)
and Dmean (41%), and bladder Dmean (37%) (all p≤0.002), with equal PTV coverage. Com-
pared to autoVMAT with equal 3 mm margin, autoROBOT reduced rectum D1cc by 5% (p =
0.002), rectum V60GyEq by 33% (p = 0.001), and rectum Dmean by 4% (p = 0.05), respectively,
with comparable PTV coverage and other OAR sparing. For autoVMAT with 5 mm margin,
18/20 plans had a PTV coverage lower than requested (<95%) and all plans had higher
rectum doses than autoROBOT (mean percentage dierences of 13%, 69% and 32% for
D1cc, V60GyEq, and Dmean, respectively (all p<0.001)).
In Chapter 5, a similar workflow was developed for automated planning in robotic Cy-
berKnife radiosurgery of benign vestibular schwannoma tumors, to explore possibilities
for reducing dose outside the PTV to potentially reduce risk of secondary tumor induc-
tion.
The goal of automated planning was to reduce the dose bath, including the occurrence
of high dose spikes leaking from the PTV into normal tissues, without worsening PTV
coverage, OAR doses, or treatment time. CyberKnife autoplans were generated for 20
patients, treated with 1x12 Gy, and compared with manually generated CyberKnife plans.
Autoplans performed as good as manual plans for all OAR sparing (largest mean dier-
ence for all OARs: ∆D2% = 0.2 Gy), while highly reducing the dose bath. With autoplans,
patient volumes receiving more than 1 or 6 Gy, were reduced by (mean/maximum reduc-
tion) 23.6/53.8% and 9.6/28.5% with autoplans compared to manual plans (p<0.001).
Autoplans also reduced dose spikes, with mean/maximum reductions of 22.8/37.2% and
14.2/40.4% in D2% for shells at 1 and 7 cm distance from the PTV, respectively (p<0.001).
The study showed that automated planning highly outperformed manual planning, re-
ducing ‘for-free’ the dose bath outside the PTV, without deteriorating PTV coverage or
OAR sparing, or significantly increasing treatment time.
137
9
Su
m
m
ar
y
Summary
In Chapter 6, Erasmus-iCycle was challenged with planning for young female mediasti-
nal lymphoma patients with large variations in tumor location, shape and size. The pur-
pose of this work was to implement an automated planning workflow to obtain adequate
target coverage with maximum sparing of breasts, heart, and lungs, and to investigate
the impact of beam configuration on plan quality.
Twenty-four coplanar and non-coplanar beam configuration approaches were consid-
ered, partly based on individualized beam angle optimization, and partly on beam angle
class solutions. Twenty-six patients were included in the study. The automated plan-
ning workflow was first validated by comparing clinically delivered, manually generated
plans (CLIN) with automatically generated plans. Next, for the beam configuration in-
vestigations, autoplans were generated with i) coplanar configurations with computer-
optimized patient-specific beam directions (CP_x with x = 5-15), ii) non-coplanar configu-
rations with patient-specific beam directions (NCP_x with x = 5-15), iii) the VMAT coplanar
beam angle class solution, and iv) the non-coplanar Butterfly VMAT (B-VMAT) class so-
lution.
Of the 645 generated autoplans, 98.8% were suited for clinical use. Compared to the
CLIN plans, autoplans had significantly enhanced PTV dose delivery and, especially for
non-coplanar autoplans with 10-15 individualized beams, also large OAR dose reductions
could be obtained. None of the investigated 24 beam configuration approaches was best
for all patients, but overall non-coplanar configurations (B-VMAT and NCP_x≥12) per-
formed clearly the best. NCP_x≥12 produced on average highly conformal plans with
favourable high dose plan parameters for the lungs and the patient, and also a low heart
Dmean. B-VMAT had reduced low-dose spread in lungs and left breast, with the practical
advantages of a faster delivery and the elimination of patient-specific BAO. Generation
of multiple plans for each new patient for a per-patient selection of the optimal beam
configuration, based on both plan quality dierences and practical considerations as
delivery time, could importantly contribute to personalization of the treatment of these
patients.
In Chapter 7, autoplanning with Erasmus-iCycle was used to explore the use of VMAT+,
i.e. coplanar VMAT supplemented with a few (≤5) non-coplanar beams, for enhancing
OAR sparing in prostate SBRT with minimal increase in treatment time compared to
VMAT. The work was inspired by successes reported for VMAT+ in liver SBRT [157]. Initially,
VMAT+5 plans, complementing VMAT with five non-coplanar IMRT beams with computer-
optimized, patient-specific directions, were generated for the 20 study patients, show-
ing large preferences for a few principal directions in the beam angle search space. Two
most preferred directions were used to define a 2-beam non-coplanar beam angle class
solution (CS) for complementing VMAT, resulting in the VMAT+CS treatment approach.
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VMAT+CS autoplans were then compared to i) VMAT, ii) VMAT+5, and iii) IMRT with 30 indi-
vidualized non-coplanar beam directions (30-NCP). Plan comparisons were performed
in terms of PTV dose, OAR sparing, and computation and treatment delivery times.
Compared to VMAT, plan quality was significantly improved with the non-coplanar
VMAT+CS. For equal PTV dose, rectum Dmean, D1cc, V60GyEq and V40GyEq were reduced by
19.4 ± 10.6%, 4.2 ± 2.7%, 39.7 ± 23.2% and 34.9 ± 0.3%, respectively (all p<0.001). Total
delivery times only increased by 1.9 ± 0.7 min compared to VMAT (9.1±0.7 min). VMAT+CS
performed equivalently to VMAT+5 regarding plan quality, while reducing optimization
times by a factor of 25 due to avoidance of BAO. VMAT+CS had larger dose bath than 30-
NCP, but with equal quality regarding all other plan parameters and with highly reduced
optimization and delivery times.
In Chapter 8, challenges and opportunities of autoplanning with Erasmus-iCycle, and
of the use of non-coplanar beam configurations are discussed. The chapter concludes
with an outlook on future research opportunities.
139

9
Su
m
m
ar
y
Samenvatting
Wanneer een patiënt is gediagnosticeerd met kanker, en met radiotherapie (bestra-
lingstherapie) behandeld gaat worden, moet er een zogenaamd bestralingsplan worden
gemaakt. Een bestralingsplan beschrijft in essentie de configuratie van het bestralings-
apparaat, en de daaruit volgende dosisverdeling in de patiënt. Het doel is om de tumor
zo goed mogelijk met een hoge dosis te bestralen, en de (onvermijdelijke) dosis aan het
omliggende gezonde weefsel zo laag mogelijk te houden.
Conventioneel wordt een bestralingsplan ‘handmatig’ gemaakt, waarbij een planner
interactief werkt met het ‘treatment planning system’ (TPS), software die het maken van
een bestralingsplan ondersteund. Hierin moeten veel keuzes gemaakt worden om een
plan van hoge kwaliteit te produceren. Dit is in de praktijk een interactieve ‘trial-and-
error’ procedure waarbij het aantal bestralingsbundels, de bundelhoeken en de ben-
odigde doelfuncties met hun parameters moeten worden vastgesteld. Bij het maken
van het plan moet rekening gehouden worden met meerdere, vaak tegenstrijdige doe-
len van de bestraling (bijv. hoge tumordosis, maar tegelijkertijd lage dosis in gevoelige
weefsels rondom de tumor), wat het plannen extra uitdagend maakt. Door de inherente
complexiteit is bij handmatig plannen de kwaliteit van het uiteindelijke bestralingsplan
sterk afhankelijk van de planner en de beschikbare tijd. Dit is het geval wanneer een
plan gemaakt wordt voor een specifieke patiënt, maar het heeft ook invloed op breder
onderzoek waarin een groot aantal plannen gemaakt moet worden om bijvoorbeeld ver-
schillende bestralingstechnieken kwalitatief met elkaar te vergelijken. Onderzoek heeft
aangetoond dat automatisch plannen met Erasmus-iCycle, een TPS ontwikkeld in Rotter-
dam, een belangrijke rol kan spelen in het substantieel verbeteren van de plankwaliteit
ten opzichte van handmatige planning, terwijl daarnaast de werklast van het handmatig
plannen ook grotendeels vervalt. Een unieke optie van Erasmus-iCycle is dat bij IMRT
niet enkel de dosisprofielen, maar gelijktijdig ook de bundelhoeken geoptimaliseerd
kunnen worden.
In dit proefschrift is Erasmus-iCycle gebruikt om systematisch de invloed van bun-
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delhoeken op plankwaliteit te onderzoeken. Daarnaast is onderzoek gedaan naar ver-
betering van plankwaliteit met het toegepaste automatisch plannen ten opzichte van
handmatige planning zoals klinisch gebruikelijk is.
In hoofdstuk 2 werd de bundelhoekoptimalisatie optie (‘beam angle optimization’,
BAO) van Erasmus-iCycle gebruikt om voor stereotactische prostaatbestraling (SBRT) on-
derzoek te doen naar het verband tussen plankwaliteit en karakteristieken van het bun-
delhoekzoekgebied, ofwel de kandidaatbundelhoeken die geselecteerd konden worden
voor het genereren van een optimaal plan. In totaal werden 1500 plannen gemaakt voor
10 patiënten met verschillende coplanaire en niet-coplaniare bundelconfiguraties en
verschillende bundelaantallen.
Er werd een duidelijk voordeel gevonden voor niet-coplanaire configuraties ten aanzien
van de sparing van gezonde weefsels. Voor het rectum, het kritieke orgaan met de hoog-
ste prioriteit, leidde een volledig niet-coplanaire configuratie tot reducties in Dgemiddeld,
V40GyEq, V60GyEq en D2% van respectievelijk 25%, 35% 37% en 8%, vergeleken met coplanair.
De plankwaliteit nam significant toe met het verhogen van het aantal bundels. Voor
coplanaire plannen konden bijvoorbeeld de rectum Dgemiddeld, V40GyEq, V60GyEq en D2%
verbeterd worden met respectievelijk 39%, 57%, 64% en 13%, wanneer 25 in plaats van 11
bundels werden gebruikt. Anderzijds resulteerde het gebruik van meer dan 25 bundels
niet in relevante verbeteringen van de plannen.
Met de aangetoonde voordelen van niet-coplanaire bundels in prostaat SBRT werd in
hoofdstuk 3 de mogelijkheid tot het creëren van een niet-coplanaire bundelhoek ‘class
solution’ (CS) onderzocht om de tijdrovende individuele BAO te vervangen zonder signi-
ficant verlies in plankwaliteit. Erasmus-iCycle werd gebruikt om 1060 plannen te gene-
reren voor 30 patiënten. Zes verschillende recepten voor het maken van een CS werden
onderzocht voor plannen met 15, 20 en 25 bundels.
Van de geteste CS recepten resulteerde er slechts 1 in CSs met 15, 20 en 25 bundels
waarvoor planverslechteringen ten opzichte van BAO verwaarloosbaar waren. Voor 25
bundels werden gemiddelde verschillen in rectum D1cc, V60GyEq, V40GyEq en Dgemiddeld
gevonden van respectievelijk 0.2 ± 0.4 Gy, 0.1 ± 0.2%-punt, 0.2 ± 0.3%-punt en 0.1 ±
0.2 Gy. Het grote voordeel van het gebruik van een CS in plaats van BAO was dat bij
gelijkblijvende plankwaliteit de rekentijden omlaag gingen met een factor 14-25.
In hoofdstuk 4 wordt het eerste systeem voor volledig automatische generatie van
klinisch bruikbare CyberKnife plannen (autoROBOT) gepresenteerd. Hiervoor werd het
Erasmus-iCycle TPS gekoppeld aan het commerciële CyberKnife TPS. Het systeem werd
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geëvalueerd voor prostaat SBRT. autoROBOT plangeneratie werd eerst gevalideerd door
vergelijking met handmatig gegenereerde, klinisch gebruikte plannen. Daarna werd voor
20 patiënten het autoROBOT plan vergeleken met twee automatisch gegenereerde VMAT
plannen (autoVMAT): één voor een CTV-PTV marge van 3 mm (zoals gebruikt in de kliniek
voor behandeling met de CyberKnife, en ook gebruikt voor autoROBOT) en één voor een
marge van 5 mm (zoals vaak gebruikt wordt voor VMAT SBRT).
Vergeleken met handmatig gegenereerde plannen verbeterde autoROBOT de rectum
D1cc (16%), V60GyEq (75%) en Dgemiddeld (41%), en blaas Dgemiddeld (37%) (alle p<0.002),
met gelijkwaardige PTV dekking. Vergeleken met autoVMAT met een marge van 3 mm
reduceerde autoROBOT de rectum D1cc met 5% (p = 0.002), rectum V60GyEq met 33% (p =
0.001) en de gemiddelde rectumdosis met 4% (p = 0.05) met vergelijkbare PTV dekking en
sparing van andere gezonde weefsels. Voor autoVMAT met 5 mm marge hadden 18/20
plannen een PTV dekking lager dan klinisch vereist. Daarnaast hadden deze plannen
hogere rectum doses dan autoROBOT (gemiddelde procentuele verschillen van 13%, 69%
and 32% voor D1cc, V60GyEq, en Dgemiddeld, respectievelijk (alle p<0.001)).
In hoofdstuk 5 wordt een soortgelijk systeem beschreven voor het automatisch gene-
reren van CyberKnife plannen voor radiochirurgie van goedaardige vestibulair schwan-
noom tumoren. De focus van het onderzoek lag op de vraag of met automatisch plannen
het dosisbad verminderd kon worden om daarmee de kans op het ontwikkelen van een
stralingsgeïnduceerde tumor te verkleinen, zonder te verliezen op plan kwaliteit voor
de tumor en de kritieke gezonde weefsels, of een toename in de bestralingstijd.
Door automatisch te plannen kon het dosisbad inderdaad substantieel verkleind wor-
den zonder in te leveren op de andere criteria. Patiëntvolumes die meer dan 1 of 6 Gy
ontvingen konden verlaagd worden met (gemiddelde/maximale reductie) 23.6/53.8% en
9.6/28.5%, vergeleken met handmatige planning (p<0.001). Automatisch gegenereerde
plannen verminderden ook de hoge dosis uitlopers vanuit de tumor richting de gezonde
weefsels (‘spikes’), met gemiddelde/maximale reducties van 22.8/37.2% en 14.2/40.4% in
D2% voor dosis op respectievelijk 1 en 7 cm afstand van het PTV (p<0.001).
Uiteindelijk werd dus aangetoond dat automatisch plannen het handmatig plannen
werd overtrofen door een ‘gratis’ reductie van het dosisbad buiten het PTV, ofwel zon-
der verslechtering van PTV dekking of sparing van kritieke structuren, of significante
toename in bestralingstijd.
In hoofdstuk 6 werd Erasmus-iCycle gebruikt om verschillende bundelgeometrieën
te vergelijken voor de uitdagende en anatomisch zeer heterogene groep van 26 jonge,
vrouwelijke patiënten met een mediastinaal lymfoom. Eerst werd Erasmus-iCycle gecon-
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figureerd voor het automatisch genereren van plannen met voldoende dekking van de
tumor en maximale sparing van de mamma’s, het hart en de longen. Vervolgens werd
met dit systeem de invloed van bundelhoekconfiguraties op de plankwaliteit onder-
zocht.
Er werden 24 coplanaire en niet-coplanaire bundelhoekconfiguraties vergeleken, deels
verkregen met patiënt-specifieke BAO en deels gedefinieerd middels ‘class solutions’.
Allereerst werd de automatische plangeneratie gevalideerd door te vergelijken met hand-
matig gemaakte plannen die gebruikt waren voor de bestraling van de patiënten (CLIN).
Vervolgens werd het systeem gebruikt om voor iedere patiënt voor elk van de 24 onder-
zochte bundelhoekconfiguraties automatisch een plan te genereren.
Van de 645 automatisch gegenereerde plannen was 98.8% geschikt voor klinisch ge-
bruik. Vergeleken met de CLIN plannen hadden de automatisch gegenereerde plannen
een significant verbeterde tumordekking, en voor niet-coplanaire configuraties met 10-
15 geïndividualiseerde bundels, ook grote dosisreducties in de kritieke organen. Geen
enkele van de 24 onderzochte bundelhoekconfiguraties was duidelijk het best voor alle
patiënten, maar over het algemeen waren niet-coplanaire configuraties duidelijk het
gunstigst. Niet-coplanaire, patient-specifieke configuraties met 12 bundels of meer re-
sulteerden gemiddeld in conformere plannen met gunstige hoge-dosis voor de longen
en de patiënt als geheel en ook in een lagere gemiddelde hartdosis. Met ‘Butterfly-
VMAT’ was de afgifte van lage doses in longen en linkerborst relatief laag met daarnaast
de praktische voordelen van een snelle dosisafgifte en een plangeneratie waarvoor de
bundelhoeken niet per patiënt geoptimaliseerd hoeven te worden. Geconcludeerd werd
dat het genereren van meerdere plannen per patiënt voor geïndividualiseerde selectie
van de optimale bundelhoekconfiguratie in belangrijke mate kan bijdragen aan de be-
handelkwaliteit van jonge, vrouwelijke patiënten met een mediastinaal lymfoom.
In hoofdstuk 7 werd automatisch plannen met Erasmus-iCycle gebruikt om voor pros-
taat SBRT te onderzoeken of VMAT+, gedefineerd als coplanaire VMAT met enkele toegevoegde
(<5) niet-coplanaire IMRT bundels, gebruikt kan worden voor het verbeteren van de spa-
ring van kritieke gezonde organen met een minimale toename in behandeltijd in ver-
gelijking met VMAT. Dit werk werd geïnspireerd door recente successen van VMAT+ voor
lever SBRT [157]. Aanvankelijk werd met Erasmus-iCycle voor 20 patiënten een VMAT+5
plan gegenereerd met geïndividualiseerde hoeken voor de 5 toegevoegde IMRT bundels.
Uit analyse van de in totaal 100 gekozen bundelhoeken bleek er een sterke voorkeur te
zijn voor een paar hoofdrichtingen. Twee van die richtingen werden gekozen als bun-
delhoek ‘class solution’ (CS) voor de gehele patiëntgroep voor het aanvullen van VMAT
(VMAT+CS). Automatisch gegenereerde VMAT+CS plannen werden vervolgens vergeleken
met automatisch genereerde i) VMAT, ii) VMAT+5 en iii) 30-NCP: IMRT met 30 geïndividu-
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aliseerde niet-coplanaire hoeken.
De plankwaliteit van VMAT+CS was significant beter dan voor VMAT; voor gelijke PTV
dosis werden rectum Dgemiddeld, D1cc, V60GyEq en V40GyEq gereduceerd met 19.4 ± 10.6%,
4.2± 2.7%, 39.7± 23.2% and 34.9± 0.3% (alle p<0.001). De totale bestralingstijd (inclusief
benodigde tafeldraaiingen voor VMAT+CS) steeg met slechts 1.9± 0.7 min vergeleken met
VMAT (9.1± 0.7 min). De plankwaliteit van VMAT+CS was vergelijkbaar met die van VMAT+5,
terwijl de optimalisatietijd een factor 25 lager was door het vermijden van patiëntspec-
ifieke BAO. Het dosisbad van VMAT+CS was groter dan dat van 30-NCP, met verder verge-
lijkbare plankwaliteit, maar met substantieel lagere optimalisatie- en behandeltijden.
Tenslotte worden er in hoofdstuk 8 uitdagingen en kansen van het automatisch plan-
nen met Erasmus-iCycle, en van het gebruik van niet-coplanaire bundelhoekconfigu-
raties bediscussieerd. Dit hoofdstuk wordt afgesloten met suggesties voor toekomstig
onderzoek.
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prioritised 3D dose-based MLC segment generation for step-and-shoot IMRT. Phys
Med Biol. 2019 [150]
8 L. Rossi, A. Méndez Romero, M. Milder, E. de Klerck, S. Breedveld, B.J.M. Heijmen.
Individualized automated planning for dose bath reduction in robotic radiosurgery
for benign tumors. PLoS ONE 2019 [144]
9 L. Rossi, R. Bijman, W. Schillemans, S. Aluwini, C. Cavedon, M. Witte, L. Incrocci,
B.J.M. Heijmen. Texture analysis of 3D dose distributions for predictive modelling
of toxicity rates in radiotherapy. Radiother. Oncol. 2018 [141]
10 M. Loi, M. Duijm, S. Baker, L. Rossi, D. Grunhagen, C. Verhoef, J. Nuyttens. Stereotac-
tic body radiotherapy for oligometastatic soft tissue sarcoma. Radiol Med. 2018
[104]
11 L. Rossi, A.W. Sharfo, S. Aluwini, M.L.P. Dirkx, S. Breedveld, B.J.M. Heijmen. First
fully automated planning solution for robotic radiosurgery - comparison with au-
tomatically planned volumetric arc therapy for prostate cancer. ACTA Oncologica
2018 [145]
12 D. Cusumano, M.L. Fumagalli, F. Ghielmetti, L. Rossi, G. Grossi, R. Lanzarotti, L.
Fariselli, E. De Martin. Sum signal dosimetry: a new approach for high dose quality
assurance with Gafchromic EBT3. J Appl Clin Med Phys. 2017 [34]
13 C. Cavedon, G. Meliadó, L. Rossi, L. Camera, I. Baglio, F. Caumo, S. Montemezzi.
High-field MR spectroscopy in the multiparametric MRI evaluation of breast le-
sions. Phys Med. 2016 [29]
14 L. Rossi, S. Breedveld, S. Aluwini, B.J.M. Heijmen . Non-coplanar beam angle class
solutions to replace time-consuming patient-specific beam angle optimization in
robotic prostate SBRT. Int J Radiat Oncol Biol Phys. 2015 [142]
15 L. Rossi, S. Breedveld, B.J.M. Heijmen, P. Voet, N. Lanconelli and S. Aluwini. On the
beam direction search space in computerized non-coplanar beam angle optimiza-
tion for IMRT-prostate SBRT. Phys Med Biol. 2012 [143]
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Oral Presentations at International Conferences
2020, ESTRO 39, Vienna, Austria.
• Automation of treatment planning process. L. Rossi (invited speaker), S.
Breedveld, B.J.M. Heijmen
• Inter-observer variability in quality scores of Pareto optimal plans E. Cagni,
L. Rossi, A. Botti Andrea, M. Iori, R. Sghedoni, C. Iotti, A. Rosca, G. Timon, S.
Cozzi, M. Galaverni, M. Orlandi, E. Spezi, B.J.M. Heijmen
2019, ESTRO 38, Milan, Italy.
• Using automated planning for bias-free plan comparison. L. Rossi (invited
speaker), A. Sharfo, S. Breedveld, B.J.M. Heijmen
• Automated (non-coplanar) beam selection for IMRT in young female lym-
phoma patients reduces OAR doses. P. Cambraia Lopes, L. Rossi, J. Leitão,
C. Janus, M. van de Pol, J. Penninkhof, B.J.M. Heijmen
• A two-beam non-coplanar class solution to supplement VMAT in prostate
SBRT. A.W. Sharfo, L. Rossi, M.L.P. Dirkx, S. Aluwini, S. Breedveld, B.J.M. Heijmen
2019, International Day of Medical Physics, Matera, Italy. Automated IMRT and VMAT ra-
diotherapy treatment planning for left breast cancer: bias-free comparison be-
tween techniques. L. Redapi, L. Rossi, L. Marrazzo, J.J. Penninkhof, S. Pallotta, B.J.M.
Heijmen
2018, NVKF Lustrum, Haarlem, The Netherlands. Texture Analysis of 3D dose distribu-
tions for toxicity predictive modelling to be applied in automated radiotherapy
planning. L. Rossi, R. Bijman, W. Schillemans, S. Aluwini, C. Cavedon, M. Witte, L.
Incrocci and B.J.M. Heijmen
2018, ESTRO 37, Barcelona, Spain.
• Multi-criterial MLC segmentation with column generation, applied to robotic
SBRT. B.W.K. Schipaanboord, S. Breedveld, L. Rossi, M. Keijzer, B.J.M. Heijmen
• Automated planning and prediction models for bias-free treatment technique
selection. A.W. Sharfo, M.L.P. Dirkx, R. Bijman, L. Rossi, T. Arts, S. Breedveld,
M. Hoogeman, B.J.M. Heijmen
2018, 10th National Congress AIFM, Bari, Italy.
• Automated planning in radiotherapy L. Rossi (invited author, teaching les-
son)
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• Texture Analysis of 3D dose distributions for toxicity predictive modelling in
radiotherapy. L. Rossi, R. Bijman, W. Schillemans, S. Aluwini, M. Witte, L.
Incrocci and B.J.M. Heijmen (Awarded presentation)
2017, ESTRO 36, Vienna, Austria. Automated planning, knowledge-based planning and
other novelties in treatment planning - how do they work and perform? B.J.M.
Heijmen, P. Voet, L. Rossi, A. Sharfo, Y. Wang, S. Breedveld
2016, EANM, European Association of Nuclear Medicine, Barcelona, Spain. Design and
Physical Performance of a Plastic Scintillator Detector to control radioactive waste
in a Nuclear Medicine Unit. F. Zito, A. D’Alessio, G. Galetta, L. Rossi, R. Benti
2016, EURO, 28th European Conference on Operational Research, Poznań, Poland. Multi-
Criteria Optimisation and Decision-Making in Radiotherapy. S. Breedveld, R. van
Haveren, L. Rossi, S. van de Water, T. Arts, A.W. Sharfo, M. Hoogeman, W. Ogryczak,
B.J.M. Heijmen
2016, ESTRO 35, Turin, Italy.
• Fully automated planning for non-coplanar CyberKnife prostate SBRT - com-
parison with automatic VMAT. L. Rossi, S. Breedveld, S. Aluwini, B.J.M. Heijmen
• Fully automated treatment plan generation using Erasmus-iCycle - the Rot-
terdam experience. M.L.P. Dirkx , A.W. Sharfo, P. Voet, G. della Gala, L. Rossi, D.
Fransen, J.J. Penninkhof, M.S. Hoogeman, S.F. Petit, A.M. Méndez Romero, J.W.
Mens, L. Incrocci, N. Hoekstra, M. van de Pol, S. Aluwini, S. Breedveld, B.J.M.
Heijmen
2016, 9th Congresso Nazionale AIFM, Perugia, Italy. First clinical system for fully auto-
mated planning for non-coplanar Cyberknife - comparison with coplanar VMAT for
prostate SBRT. L. Rossi, S. Breedveld, S. Aluwini, B.J.M. Heijmen
2015, IPEM Radiotherapy Treatment Planning conference, London, UK. Automated IMRT
and VMAT planning for standardization in radiotherapy with improved treatment
quality and reduced workload. B.J.M. Heijmen, P. Voet, L. Rossi, A. Sharfo, S. van
de Water, M.L.P. Dirkx, M. Hoogeman, S. Breedveld
2015, 28th Annual EANM Congress, Hamburg, Germany. 18F-FDG whole body PET/CT dose
evaluation in pediatric patients. F. Zito, G. Galetta, L. Rossi, C. Canzi, L. Florimonte,
R. Benti
2015, ESTRO 3rd Forum, Barcelona, Spain.
• Coplanar and non-coplanar optimization in prostate SBRT. L. Rossi (invited
speaker), S. Breedveld, S. Aluwini, B.J.M. Heijmen
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• Automatic planning strategies. B.J.M. Heijmen, P. Voet, M.L.P. Dirkx, A.W. Sharfo,
L. Rossi, S. Van de Water, D. Fransen, J. Penninkhof, M.S. Hoogeman, S.F. Petit,
A.M. Méndez Romero, J.W. Mens, L. Incrocci, S. Breedveld
• Sum signal dosimetry: a novel approach for high dose patient specific quality
assurance with Gafchromic EBT3. D. Cusumano, M.L. Fumagalli, F. Ghielmetti,
L. Rossi, G. Grossi, R. Lanzarotti, L. Fariselli, E. De Martin
2014, 8th European Conference on Medical Physic, EFOMP, Athens, Greece. Fully auto-
mated treatment plan generation in daily routine. B.J.M. Heijmen, P. Voet, M.L.P.
Dirkx, A. Sharfo, L. Rossi, D. Fransen, J. Penninkhof, M. Hoogeman, S. Petit, J.W.
Mens, A. Méndez Romero, A. Al-Mamgani, L. Incrocci, S. Breedveld
2014, ESTRO 33, Vienna, Austria. Development of a beam angle class solution to replace
full beam angle optimization in non-coplanar prostate SBRT. L. Rossi, S. Breedveld,
S. Aluwini & B.J.M. Heijmen
2013, 2nd ESTRO Forum, Geneva, Switzerland. Strongly reduced rectum dose for prostate
treatment with non-coplanar beam setup of a CyberKnife equipped with an MLC.
L. Rossi, B.J.M. Heijmen, S. Breedveld, P. Voet, S. Aluwini
2013, 1st European Conference on SRS/SBRT & IG-IMRT, Milan, Italy. Clinical added va-
lue of non-coplanar treatments. B.J.M. Heijmen, L. Rossi, S. Breedveld, P. Voet, S.
Aluwini
Posters at International Conferences
2020, ESTRO 39, Vienna, Austria.
• Individualized Beam Angle Selection for MR-Linac Treatment of Rectal Can-
cer Patients R. Bijman, L. Rossi, T. Janssen, P. de Ruijter, B. van Triest, S.
Breedveld, J.J. Sonke, B.J.M. Heijmen (poster discussion)
• Large treatment plan quality enhancement in robotic radiotherapy M.K. Giżyńska,
L. Rossi, W. den Toom, M. Milder, K. de Vries, J. Nuyttens, L. Incrocci, B.J.M.
Heijmen
2019, ESTRO 38, Milan, Italy. First system for fully automated multi-criterial planning for
an MR-Linac applied to rectal cancer. R. Bijman, L. Rossi, T. Janssen, P. de Ruijter, C.
Carbaat, B. van Triest, S. Breedveld, J.J. Sonke, B.J.M. Heijmen (poster discussion)
2018, ESTRO 37, Barcelona, Spain.
• Texture Analysis of 3D dose distributions for toxicity predictive modelling in
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radiotherapy. L. Rossi, R. Bijman, W. Schillemans, S. Aluwini, M. Witte, L.
Incrocci and B.J.M. Heijmen (poster viewing)
• Enhanced prostate SBRT using VMAT + a single computer-optimized non-coplanar
IMRT beam. A.W. Sharfo, L. Rossi, M.L.P. Dirkx, S. Aluwini, S. Breedveld, B.J.M.
Heijmen
2017, ESTRO 36, Vienna, Austria. Automated planning to reduce integral dose in robotic
radiosurgery for benign tumors. L. Rossi, A. Méndez Romero, M. Milder, E. de Klerck,
S. Breedveld, B.J.M. Heijmen
2014, ASTRO 56th Annual Meeting, San Francisco, USA. Fully Automatic IMRT and VMAT
Treatment Planning in Routine Clinical Practice. B.J.M. Heijmen, P. Voet, M.L.P.
Dirkx, A. Sharfo, L. Rossi, D. Fransen, J. Penninkhof, M. Hoogeman, S. Petit, J. Mens,
A. Méndez Romero, A. Al-Mamgani, L. Incrocci, S. Breedveld
2013, 8th Annual Meeting AIFM, Turin, Italy. IRIS and fixed collimators comparison for
CyberKnife stereotactic radiosurgery of petroclival meningiomas. L. Rossi, M.L. Fu-
magalli, F. Ghielmetti, M. Marchetti, L. Fariselli, E. De Martin
2012, AAPM 54th Annual Meeting, Charlotte, NC, USA. On the beam direction search space
in computerized non-coplanar beam angle optimization for IMRT; prostate SBRT.
L. Rossi, P. Voet, S. Breedveld, S. Aluwini, B.J.M. Heijmen
2012, ESTRO 31, Barcelona, Spain. On the extent of the beam direction search space in
computerized non-coplanar beam angle optimization for IMRT. B.J.M. Heijmen, L.
Rossi, S. Breedveld, P. Voet, N. Lanconelli, S. Aluwini
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PhD Portfolio
Summary of PhD training and teaching
Name PhD student: Linda Rossi PhD period: 2013 - 2019
(0.6 FTE, equivalent to 4 years 1.0 FTE)
Erasmus MC Department: Radiation Oncology Promotor: Prof. dr. B.J.M. Heijmen
Research School: Molecular Medicine Copromotor: Dr. ir. S. Breedeveld
1. PhD training
General courses
 Programming techniques in MATLAB (MathWorksC) Turin, IT 2010
 Research Integrity (Erasmus MC) Rotterdam, NL 2014
 Programming with Python (Erasmus MC) Rotterdam, NL 2016
Specific courses
 Physics for clinical radiotherapy (ESTRO) Budapest, HU 2010
 IGRT, Respiratory movement control and advanced imaging in radiotherapy 2012
(AIFM) Verona, IT
 Statistics for radiotherapy data (ESTRO 32, 2nd Forum) Geneva, CH 2013
 Exposition evaluation to incoherent artificial optical radiation 2013
(ANPEQ) Milan, IT
 Advanced semiconductor dosimetry in radiation therapy: current research
and future perspectives (IRCCS INT) Milan, IT
2013
 Medical Physicist contribution in physical risk evaluations in hospitals: TU
81/08 (AIFM) Milan, IT
2013
 Neutron contamination in radiotherapy beams (AIFM) Como, IT 2013
 Current Advances in Treatment Planning Optimisation (ESTRO 33) Vienna, AT 2014
 Voxel based dosimetry in nuclear medicine therapy with tomographic SPECT
and PET (AIFM) Rome, IT
2015
 Incorporating Imaging in Radiation Oncology Treatment Delivery 2015
(ESTRO 34, 3rd Forum) Barcelona, ES
 QA for advanced MR procedures (AIFM) Brescia, IT 2015
179
 Multidimensional dosimetry systems (ESTRO 35) Turin, IT 2016
 Statistics applied to biomedical research (AIFM) Milan, IT 2016
 Predictive models for external radiotherapy eects (AIFM) Milan, IT 2016
 Small and modulated photon field dosimetry (AIFM) Verona, IT 2016
 Multimodality imaging in radiation oncology to improve target definition and
modified dose prescription (ESTRO 36) Vienna, AT
2017
 Big-Data, Radiomics and Artificial Intelligence (AIFM) Reggio Emilia, IT 2017
 MRI physics for applications in radiation oncology (ESTRO 37) Barcelona, ES 2018
 Machine learning for physicists (ESTRO 38) Milan, IT 2019
 Medical Physics Residency Courses (Milan University) Milan, IT 2012-
2016
Seminars and workshops
 Automate or Perish (1st ESTRO Physics Worskhsop) Glasgow, UK 2017
International conferences
 ESTRO 32 (2nd Forum) Oral presentation Geneva, CH 2013
 ESTRO 33 Oral presentation Vienna, AT 2014
 ESTRO 34 (3rd Forum) Invited speaker: Symposium Barcelona, ES 2015
 9th National Congress AIFM Oral presentation Perugia, IT 2016
 ESTRO 35 Oral presentation Turin, IT 2016
 ESTRO 36 Poster Vienna, AT 2017
 ESTRO 37 Poster viewing Barcelona, ES 2018
 10th National Congress AIFM Oral presentation Bari, IT 2018
 10th National Congress AIFM Invited speaker: Teaching lesson Bari, IT 2018
 ESTRO 38 Invited speaker: Symposium Milan, IT 2019
 ESTRO 39 (2020) Invited speaker: Symposium Vienna, AT 2020
National conferences
 RKF-Kringdag Oral presentation Amsterdam, NL 2016
 NVKF Lustrum Oral presentation Haarlem, NL 2018
Other
 CyberKnife physics, Italian
user meeting
Invited speaker: 2 oral presentations Milan,
IT
2015
 Raystation user meeting Invited speaker: Oral presentation Siena, IT 2018
 Chair invitation ESTRO 39 Chair Vienna, AT 2020
 Peer-reviewed more than 15
papers in 7 journals
Peer reviewer Radiotherapy and Oncol-
ogy, International Journal of Radiation Oncol-
ogy Biology Physics, Physics in Medicine and
Biology, Medical Physics, Physica Medica and
International Transactions in Operational Re-
search, Scientific Reports Nature
2013-
2020
180
2. Teaching
Internal Lecturing
 Texture analysis: what is it? Application Journal Club 2016
 Tumor Tracking with an MLC, based on Calypso or kV-
Imaging
Journal Club 2017
 Automated planning for robotic prostate SBRT: non-
coplanar Cyberknife comparison with coplanar autoVMAT
Refereeravond
Radiotherapie
2018
 Texture Analysis of 3D dose distributions for predictive
modelling of toxicity rates in radiotherapy
Research Day 2018
 Deep learning in radiotherapy treatment planning Journal Club 2019
 Automated planning for Low-Middle Income Country
(LMIC)
Research Day 2019
Supervising and Tutoring
 Joana Leitão Bachelor Student, Lisboa University 15 July 2018–15 Sept 2018
 Laura Redapi Medical Physics trainee, Florence 15 Sept 2018–15 Dec 2018
 Sven Meijer Master Student, Delft University 1 Sept 2018–30 Mar 2019
 Cecilia Collá Ruvolo Post Master, Turin University 1 Jan 2019–30 Mar 2019
 Rik Bijman PhD Student, Erasmus MC 1 Aug 2017–Now
 Ilja Briggeman Master Student, Delft University 8 Sept 2019-Now
3. Distinctions and awards
 Young medical physics best oral presentation, Adele Ri-
naldi award, 10th National Congress AIFM
Bari, IT 2018
181

Curriculum Vitae
Linda Rossi was born in Rimini, Italy on October 16th
1987. After completing mandatory studies in her home-
town, she moved in 2006 to Bologna to study physics
at the Alma Mater Studiorum Bologna University.
Linda did her bachelor thesis in neutrino research
in Bologna, collaborating with Gran Sasso INFN labo-
ratory and CERN, within the OPERA experiment. After
obtaining her physics bachelor degree in 2009 (109/110), she felt more attracted towards
medical applications and she attended applied physics classes in Bologna, focused on
a Master degree in medical physics. In 2011, she performed her master thesis project
in the Erasmus Placement project, at the Department of Radiation Oncology, Erasmus
Medical Center, in Rotterdam, The Netherlands. She got her physics master degree at the
end of 2011 (110/110 cum laude), with a thesis in optimization of radiotherapy planning.
In 2012, she entered the medical physicist training program in Milan, Italy. She fol-
lowed courses and got trained in radiotherapy, nuclear medicine, radioprotection and
diagnostic techniques, in three dierent institutes in Milan. In 2016, she ocially became
a Medical Physicist, with a research thesis in high field nuclear magnetic resonance for
breast tumors, conducted in Verona Hospital, Italy.
During the training for becoming a medical physicist, Linda kept actively collaborating
with the Erasmus Medical Center in Rotterdam on research projects related to plan op-
timization, intensively travelling between the two countries. After the completion of the
training program, she moved to The Netherlands and these researched were continued
as PhD project under the supervision of Prof. dr. Ben Heijmen and Dr. ir. Sebastiaan
Breedveld.
Currently Linda has a postdoc position in Rotterdam to continue her research on au-
tomation and optimization of radiotherapy treatment planning.
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Automation of the treatment plan generation in
radiotherapy showed to play a key role in patient care. 
It can highly improve plan quality, reduce planner
influence, increase standardization and easily generate 
a high number of plans.
At the Erasmus MC, an automated treatment planning 
system has been developed, called Erasmus-iCycle.
It automatically generates high-quality Pareto-optimal 
plans and it can also automatically define
patient-specific optimal beam directions, to overcome 
the not trivial manual beam selections.
In this thesis, Erasmus-iCycle has been used to improve 
plan quality and to investigate the impact of treatment 
techniques and beam directions. The latter, especially 
with focus on the added value of the non-coplanar 
beam setup, compared to coplanar setup.
ISBN: 978-94-91462-50-4
